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72 Chinese medicinal herbs, 8 formulae of tonics,
4 patent medicines, 5 purgative formulae and 16
Cantonese preserved food items commonly consumed in
Hong Kong were tested for the induction of Epstein-Barr-
virus (EBV) early antigen (EA) in the Raji cell line.
Both ether extract and water extract were prepared for
each test item except the Cantonese preserved food of
which only ether extracts were prepared.
2.
Among the 72 Chinese medicinal herbs tested, only
Daphne genkwa gave positive results. It showed EBV-EA
inducing activity for all concentrations prepared in
both extracts. Its EBV inducing activity was comparable
to those of the strong EBV inducers such as Croton oil,
Euphorbia karisui and Tung oil.
3.
2 of the 5 purgative formulae gave positive
results for all concentrations prepared in both-
extracts.
4.
All the 8 formulae of tonics, 4 patent medicines,
3 of the 5 purgative formulae and 16 Cantonese
preserved food showed no EBV-EA inducing activity.
5.
20 of -the 72 Chinese medicinal herbs which were
found to give negative results after 48 hours of-
incubation were chosen to perform the study of repeated
exposure of Raji cells to the Chinese medicinal herbs.
6.
All the 20 herbs tested gave negative results
after 10 days of repeated exposure.
7.
Sodium selenite was tested for inhibition of EBV-
EA activation in the Raji cell line using Daphne genkwa
as the EBV inducing agent. 5 different concentrations
of Daphne genkwa were used.
8.
Sodium selenite was found to be toxic to Raji
cells in the range of concentrations 1.25 ug/ml to 5.
ug/ml.
9.
There was suppressive effect of sodium selenite
(0.25-1.25 ug/ml) on EBV-EA activation. Approximate
dose-dependent pattern was observed.
10.
In conclusion, Daphne genkwa, the Chinese
medicinal herb which shows strong EBV inducing activity
both in the study of Zeng and his associates and the
present study, is not commonly prescribed by doctors of
traditional Chinese medicine in Hong Kong. Further
studies should be carried out to investigate the role
of it as tumour promoter.
11.
The present result that selenium has inhibitory
effect on EBV-EA expression in Raji cells suggests that
selenium may have anti-promoter property.
1I INTRODUCTION
In 1964 Epstein and associates [1] described the
presence of a herpes-like virus in cultured Burkitt's
lymphoma (BL) cells. The virus was shown to differ from
other known- herpes viruses [2, 3], subsequently the
name Epstein-Barr virus (EBV) was adopted.
EBV is present everywhere among humans and is
transmitted horizontally, infecting all human
populations [4, 5, .6, 7, 8]. Primary infection usually
occurs during childhood without symptoms [9] and is
accompanied by seroconversion. After infection, the
viral genome persists in human B lymphocytes, in a
latent state throughout life. EBV shows biological
activity in vitro only on interaction with human B
lymphocytes, which are the cells that have virus,
receptors.
Five different expressions of EBV determined
antigens were found. Four of them were discovered by
the use of naturally occurring human antibodies:-
(1) EBV nuclear antigen (EBNA) [10]:
A DNA-binding nonhistone protein probably acting as
a gene regulator [11].
2(2) Membrane antigen (MA) [12]:
It has been subtyped into early (EMA) and late
(LMA) components [13, 14].
(3) Early antigen (EA) [15]:
It has also been subtyped into two components:
Restricted (R) and Diffuse (D).
(4) Viral capsid antigen (VCA) [3].
In addition, there is a fifth antigen, lymphocyte-
detected membrane antigen (LYDMA) [17, 18].
Since the discovery of EBV, several EBV genome-
carrying human lymphoblastoid cell lines have been
derived from BL [19, 20, 21, 22]. These cell lines are
invaluable tools in the study of the role of EBV in
nasopharyngeal carcinoma (NPC) especially because the
tumour cells of NPC grow only slowly in culture and for
a* very limited period. Raji is a virus non-producer
cell line which carries the EBV genome.
In 1981, Ito et al. [23] designed a short term in
vitro assay method for detecting tumour promoters,
utilizing the activation of EBV expression in EBV
genome-carrying human lymphoblastoid cells with Raji
cells as the indicator.
Immunological evidence gathered in the five years
3following the discovery of EBV demonstrated that this
virus closely associated not only with BL but also with
another human neoplasm, NPC [24, 25].
NPC can be observed almost anywhere in the world
[26, 27, 28], but at vastly different frequencies. Its
frequency is remarkably high in certain areas of
southern China, the Guang-dong Province in particular,
and in Hong Kong. .Most of the people in these places
are Cantonese. Besides EBV as a possible etiological
agent, it has been suggested that both genetic and
environmental factors contribute to the causation of
NPC.
Since Cantonese has particularly high incidence
rate of NPC, there are reasons to believe that their
habit of taking Chinese medicinal herbs as those to
clear heat or dispel poisons, remedy for mild
ailments or in tonic tea or preserved Cantonese food
may contribute to the high incidence rate of NPC.
Therefore the aim of this study is to find out whether
commonly consumed Chinese medicinal herbs and Chinese
food items in Hong Kong are tumour promoters as defined
by the induction of EBV-specific early antigen in the
Raji cell line using the assay method established by
4Ito and his associates [23].
3II LITERATURE REVIEW
A. Epstein-Barr virus (EBV)
(a) Infections of EBV
Natural primary infections of EBV usually takes
place in childhood without disease manifestations [9]
and is always followed by permanent seroconversion. The
virus is harboured for the rest of the individual's
life. Firstly, this harbouring is manifested as a
nonproductive latent infection of a small number of
circulating lymphocytes. Secondly, a productive
infection somewhere in the oropharynx or nasopharynx
with liberation of infectious virus into the buccal
fluid. The infectious virus shed in this way into
buccal fluids is responsible for horizontal
transmission for all natural primary infections. If
primary infection is in late adolescence or young
adulthood, it leads to Infectious mononucleosis (IM) in
about 50% of cases [29].
The productive infection of EBV predominantly
involves sites communicating with the buccal cavity.
Recent studies have shown that cultured human
6epithelial cells can be both transfected [30] and
directly infected [31] in vitro, and these findings are
matched by experiments showing EBV DNA and RNA in
oropharyngeal epithelial cells taken directly from IM.
Furthermore, the presence of' viral nucleic acids in
such cells was paralleled by and correlated with the
presence of infectious virus in the salivary fluid
[32]. Thus oropharyngeal epithelial cells seem to
provide the target for productive infection. However,
how the virus gains entry to them is still a mystery.
It is well established that B lymphocytic cells carry
virus receptors [33]. Recently, it has been suggested
that T lymphocytes may also have the virus receptors
(34). It may be necessary for the virus to pass from
such cells in Waldeyer's ring viaintercellular bridges
in order for oropharyngeal epithelial cells to become
infected.
It should be noted that all Chinese have primary
infection of EBV by the age of twenty. This is similar
to the Africans who all have primary infection of EBV
even at a earlier age in the case of Burkitt's
Lymphoma. In contrast to these two groups, people in
western countries do not have 100% infection even in
7adults [35, 36, 37, 38].
(b) Virus-carrying B cells in circulation
The latent infection of lymphocytes certainly only
involves B cells because apart from their possession of
receptors for the virus, cells of this type have been
shown actually to carry the viral genome in vivo [39].
It is the small number of these genome-carrying B
lymphocytes in the peripheral circulation which
provides the starting point for the continuous EBV-
carrying lymphoblastoid lines that can be established
in vitro from blood or lymph-node biopsies of
seropositive people.
(c) EBV genome-carrying lymphoid cell lines
In 1964, Pulvertaft [19] and Epstein and Barr.. [2]
independently described the first cell lines from
tumour biopsies of patients with BL. Before this,
attempts to cultivate normal and malignant
hematopoietic tissue in vitro had usually led to a
gradual deterioration and resulted in death of the
various cell types within. weeks or months [40, 4.1].
Successful establishment of leukemia and lymphoma cell
8lines were soon reported [42, 43, 44, 45, 46]. In 1967,
Moore et al. [47] reported continuous lymphoid cell
lines from healthy individuals. The view that all lines
derived from malignant hematopoietic tissue were
progeny of the neoplastic cell population in vivo was
then in question. It is now clear that blood and
hematopoietic tissue of donors without neoplastic
disease contained cells, normal or preneoplastic, with
the capacity for infinite proliferation in vitro and
that the morphology and growth properties of lymphoid
cell lines are essentially similar regardless of normal
or malignant derivation.
The studies on the relationship of EBV to the
establishment of lymphoid cell lines in vitro further
strengthened the assumption that the biologic nature of
most of these lines was identical. Most of the lymphoid
lines were found to contain EBV particles in a small
fraction of the cells by electron microscopy. The
immunofluorescence test for detection of EBV antigens
by Henle and Henle, [3] further supported this
assumption. For the lymphoid cell lines of both normal
and malignant derivation screened for the presence of
EBV, most of them were found to contain a low fraction
9of VCA positive cells [48, 49, 50].
Cell lines could be established spontaneously from
peripheral blood and lymphoid tissue only from EBV-
seropositive donors [51, 52]. With the development of
more sensitive techniques,. particularly nucleic acid
hybridization [53, 54] and immunofluorescence staining
for EBV nuclear antigen (EBNA) [55], it was found that
even the seemingly EBV-negative lines carried EBV
genomes.
Therefore it was suggested that all lymphoid cell
lines, regardless of origin, might represent the same
type of EBV-immortalized lymphoid cell that for
proliferation in vitro was strictly dependent on the
presence of the EBV genome.
Two main types of EBV-carrying cell lines have
been classified: BL lines and lymphoblastoid lines. The
BL lines are derived from the malignant cells in BL-
tumour biopsies and have a monoclonal origin [56]. They
are tumourigenic when injected subcutaneously into nude
mice with few exceptions [57]. The lymphoblastoid
lines, which may be derived both from normal and
neoplastic hematopoietic tissue, are polyclonal and
nontumourigenic shortly after establishment [58]. Some
10
of the representative cell lines of each type are
listed in Table 1.
Table 1 Classification of EBV-carrying lymphoid cell
lines
Representative cell linesType of cell line
Raji [19], EB3 [20],BL lines
Daudi [21], P3HR-1 [22].
Lymphoblastoid lines 833L [59], U-303 [60],
IM lines [61],
CCRF-SB [62].
(d) Activation of the EBV genome in vitro
Lymphoid cell lines harbouring EBV genome can also
be classified -according to their virus producing
property: the producer and non-producer cell lines.
The producer cell lines are those in which
spontaneous activation of EBV occurs in a varying
percentage of cells and usually leads to synthesis of
complete virions. One example of these cell lines is
11
P3HR-1 [22].
The non-producer cell lines are those in which
spontaneous activation of EBV occurs rarely and leads
only to the abortive form of the virus replicative
cycle without production of virions. Raji cell line
[19] is a typical example of these cell lines.
Immunofluorescence has been employed most
extensively for detecting intracellular antigens
associated with productive EBV infection following
spontaneous or induced activation. The first antigen to
appear in cells in which the genome is activated to a
productive cycle is the early antigen (EA), which has
been subtyped to restricted (R) diffuse (D) components
by immunofluorescence [15]. The EA complex is
presumably composed of nonstructural antigens and is
synthesized prior to replication of free virus DNA in
productively infected cells [63]. The EA complex
appears first in--the nucleus and later is also found in
the cytoplasm [64]. The virus productive cycle in
activated non-producer, cells is aborted subsequent to
the synthesis of EA [65] and prior to the synthesis of
free virus DNA. Synthesis of EA is sufficient to ensure
cell death [66]. However, the virus productive cycle*in
12
activated producer cells progresses beyond EA to the
synthesis of free virus DNA and the second antigen
complex, viral capsid antigen (VCA) [3], consisting
virus structural proteins.
(e) Activation.of EBV genome by chemicals
Chemicals which are reported to induce EBV in EBV
genome-carrying lymphoid cells can be classified into
four main groups.
(i) Halogenated pyrimidines
Activation of EBV was achieved with 5-
bromodeoxyuridine (BUDR) in human lymphoblastoid cells
[67] and NPC cells [68]. However, 5-iododeoxyuridine
(IUDR) has proven more efficient--and is used in most
studies today [69, 70].
(ii) Short chain--fatty acids
Luka et al. [71] reported that n-butyrate was
found to increase the,number of virus producer cells to
a dramatic extent in the EBV-carrying P3HR-1 and B95-8
lines. Induction was also seen in the non-producer Raji
and the low producer Daudi lines, but at a much lower
13
level..
Later it was found out that not only the n-butyric
acid had EBV inducing activity, but also the n-valeric
acid was found to induce EBV EA and VCA at an
appreciate level in the P3HR-1 line [72]. Furthermore,
i-valeric acid showed a considerably lower, but
significant level of activity while the i-butyric acid
was inactive. Interestingly all other fatty acids with
either a chain shorter than butyric or longer than
valeric showed only a marginal effect or none at all.
Therefore it has been suggested that the decisive
factor for EBV inducing capacity of the fatty acids
concerns the length of the carbon chain and also
configuration of the basic structure of the molecules.
(iii) Tumour-promoting phorbol and other diterpene
ester
It is well established that the tumour promoter of
diterpene type 12-O-tetradecanoylphorbol-13-acetate
(TPA) can induce EBV.,from EBV genome-carrying human
lymphoblastoid cells [73]. Ito et al. [74] reported
that the combined usage of n-butyrate and TPA or the
oily extracts from Croton tiglium, Euphorbia lathyris
14
or Euphorbia tirucalli exerted a marked effect on
induction of EBV associated EA and VCA in EBV genome-
carrying human lymphoblastoid cell lines. In producer
P3HR-1 cells, such an effect was additive. However, in
non-producer Raji cells, a greatly enhanced synergistic
effect occurred. From Fig.l, it can be observed that
the proportion of EBV EA-positive cells increases from
below 0.01 to 30-40o.with this treatment.
Based on such findings, Ito et al. has established
a synergistic assay system in which Raji cells are
cultured in basic medium containing short-chain fatty
acid (inducer A) and the test substance (inducer B)
(Fig. 2).
If 4 mmol/l n-butyrate is used in the assay system
as inducer A, then the test -,substances can be
substituted for inducer B, and their potency as EBV
inducers or tumour promoters can be screened in the
test. Alternatively, to look for EBV inducers of short-
chain fatty acid type, 20 ng/ml TPA is incorporated the
system as inducer B, and the substances to be screened
are tested to see if they can act in the role of
inducer A.
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It has been used to study the anti-promoter effect of
retinoic acids and other inhibitory agents [69].









culture 48 h. 37c (CO2 incubator)
Smears-stained by high titre NPC serum
for EBV EA-producing cells(%)
This synergistic assay system seems to be
applicable to the mass screening of tumour promoters,
particularly those in man. By using this system, Ito..et
al. [75] has tested plant diterpene esters derived
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al. [75] has tested plant diterpene esters derived
mostly from the Euphorbiaceae and Thymelaeaceae
families, indole alkaloid compounds produced by certain
strains of soil micro-organisms and factors in
physiological fluids.
The TPA and its related compounds, 4-O-methyl-PMA
and PDD, all of which are known to be potent tumour
promoters were found to have positive reaction. Among
the ether extracts from the Euphorbiaceae plants
tested, in addition to Croton tiglium, Euphorbia
lathyris and E. tirucalli, which have been reported to
have strong EBV inducing activity [76] in the system,
C. macrostachyus, C. megalocarpus and Jatropha curcas
showed' a strong positive reaction while the extract of
E. pulcherrima was weakly positive and those from E.
hirta and C. crassifolius were inactive.
(iv) Indole alkaloids
Ito et al. [75] has also found that among some
toxic metabolites of streptomyces tested in the
synergistic assay system, teleocidin was found to give
a definite positive reaction. in the system. Its EBV EA-
inducing activity was comparable to that of TPA.
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Teleocidin was first obtained from mycelia of a variant
strain of streptomyces mediocidicus [77] and its tumour
promoting potency has been well established [78].
fl RPlationshius of EBV to human diseases
EBV is found to be closely associated with three
human diseases Infectious -mononucleosis (IM) and two
malignancies: NPC and. BL. Epidemiology studies of these
three diseases indicate unique patterns in each of
them: high incidence rates of BL in Africans, NPC in
Chinese and IM in Westerners, suggesting that besides
EBV as an etiological agent, genetic and environmental
factors may be involved in the causation of these
diseases.
rl Ralaticnshin of EBV to IM
IM is an acute and self-limiting
lymphoproliferative syndrome with a geographical
distribution restricted to temperate climates and high
socio-economic groups.,, This.- disease is most prevalent
in persons 14 to 25 years of age, but does not seem to
be highly infectious. Well-documented cases have
suggested an incubation period varying from 4 to' 7
19
weeks following contact with infected partners,
involving intimate kissing.
IM is practically nonexistent in developing
countries this is not because of failure to search for
this diseases in these areas, but rather because of the
fact that the disease is absent when primary infection
by EBV takes place too early in life in these places.
The first suggestion that EBV might be
etiologically related to IM was obtained when a
laboratory technician who previously had no antibodies
to the virus, as determined by indirect
immmunofluorescence [3] seroconverted in the course of
this disease [79].
It was quickly found that sera from IM patients
uniformly showed elevated titres of antibodies to EBV,
which actually were directed against EB VCA [3].
Results of studies at Yale University indicated that
all the pre-illness sera had no antibodies to VCA,
whereas consecutive acute phase and convalescent sera
from the same patients showed high and, in part, still
rising anti-VCA titres [80].
In addition, lymphoid cell lines showing small
proportions of VCA-positive cells, were readily
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established from leukocytes of nearly every IM patient
tested they were obtained at a reduced frequency from
leukocytes of donors with past histories of IM but not
from leukocytes of individuals without antibodies to
EBV [81]. These observations strongly indicated that
EBV is the cause of IM, a conclusion subsequently
confirmed by similar observations and extended by
additional evidence [82, 83, 84].
(ii) Relationship of EBV to BL
BL first came to be understood as a distinct
entity when it was realized that a variety of lymphoid
tumours seen frequently in children in Africa were all
manifestations of a single malignant lymphoma syndrome
[85] which had not been recognized before. In those
parts of Africa where the tumour is common, it has been
found.to be commoner than all other malignant tumours
of children added-- together, with a peak incidence at
about 6-7 years of age [86].
It is noteworthy that 100% of patients with
African BL have antibodies to EBV VCA, indicating that
all individuals with the tumour have been infected by
the virus. Even more striking evidence that EBV in some
21
ways was actually causally related to African BL has
been reported. A 7-year prospective seroepidemiologic
survey in Uganda has followed 42,000 children and found
among them 12 cases of BL from whom pre-disease serum
samples were available for study. This uniquely
valuable material has shown that individuals who
develop BL already have remarkably raised titres of
antibodies to VCA months or years before clinical onset
of the tumour, and the data on this have made it
possible to calculate the risk factor attached to such
unusually marked responses to this EBV antigen so long
before the disease. Thus the risk of developing BL was
approximately 30 times higher for those with a VCA
antibody titre of two doubling dilutions or more above
the normal control population [87], a risk appreciably
greater than that for heavy cigarette- smoking and
bronchogenic carcinoma [88].
Although EBV particles have never been observed
directly in BL biopsy material [89, 90], it was obvious
from the outset 'that at least some of the cells
haboured the virus genome, since a productive cycle of
virus replication was activated by the in vitro
environment when the cells were placed in culture
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[91] in deed it was this activation which allowed EBV
to be discovered in the first place, when such cultured
cells were examined by electron microscopy [92].
Confirmation for the presence of the EBV genome in
BL cells was obtained by showing that live cells fresh
from tumours expressed the EBV-determined MA [93, 94].
It has now been established beyond doubt by
nucleic acid hybridization experiments that every
tumour does in fact contain multiple copies of EBV DNA
[95, 96] which are responsible for the expression of
the EBNA demonstrable by anticomplement
immunofluorescence [97] and the LYDMA shown by in vitro
T-cell cytotoxicity tests [98. 99]. The expression of
these various neoantigens in BL cells, particularly
those in the cell. membrane, provides the explanation of
the strong antigenicity of the tumour observed in early
clinical work.
(iii) Relationship of EBV to NPC
Besides BL, 'another human malignancy, NPC, has
been shown to have an almost equally close relationship
with EBV. However, it should be noted that only
undifferentiated or poorly differentiated NPC (i.e.
23
WHO-2 or WHO-3) are associated with EBV whereas
moderately differentiated to well differentiated NPC
(WHO-1) are not.
The first hint of an association between EBV and
NPC was provided by the demonstration of antibodies to
the virus in sera from a substantial proportion of
individuals with NPC [100]. Extensive
seroepidemiological studies using immunofluorescence
techniques have confirmed and amplified this. It is now
known [101, 102] that over 90% of patients with
undifferentiated NPC have IgA antibodies to VCA,
usually at high titre, in contrast to patients with
carcinomas of the hypopharynx or oropharynx or with
tumours' of the nasopharynx other than carcinoma, who
are either EBV antibody-negative or positive at low
titre.
The pattern of antibody responses in NPC to other
EBV-determined antigens shows specific characteristics
and variations that accompany clinical events in the
course of the disease. Although antibodies to all the
antigens are raised, those directed against the diffuse
type of early antigen (EA-D) [103] predominate in a
very unusual way [104]. and there is an almost
24
invariable and curious production of IgA antibodies to
EBV VCA [105]. Progress of NPC from early to later
stages is accompanied by increases in all antibody
levels. Successful treatment is characterized by loss
of anti-EA-D and a gradual decline in the level of
antibodies to VCA.[106].
Since patients with NPC have particularly high
titres of IgA to VCA and EA, today tests for these
antibodies are being used in China on a large scale to
screen populations with a high incidence of the tumour
both for early detection of tumour and to identify and
follow prospectively individuals marked as high risk
cases by their serological profiles [107, 108]. This
remarkable new development represents the first example
of mass screening based on viral ..serology for the
detection of a human cancer.
As, in BL, EBV particles were not found in fresh
biopsies of NPC by electron microscopy. Although
cultures of NPC cells cannot be maintained for more
than a few weeks, during this period EA synthesis was
induced in a few of the cells by exposure of the
cultures to BUDR [109]. Infectious EBV synthesis
occurred also during passage of NPC fragments in nude
25
mice [110].
Following the initial demonstration of EBV DNA in
NPC biopsies in amounts equivalent to multiple genomes
per cell [111], viral DNA was found in every
satisfactory NPC biopsy from patients in China,
Singapore, Greenland, the United States and other
countries [112, 113, 114]-. Wherever this tumour has
been studied, it has invariably been found associated
with EBV genomes, which provides strong evidence of a
causal relationship of the virus to the tumour.
Moreover, passage of NPC biopsy fragments in nude
mice resulted in growth of the carcinoma cells but loss
of the human lymphocytes [115, 110].. Although the
malignant cells grew only slowly and could not be
passed more than two or three times,-,the passed tumours
contained EBV DNA in amounts comparable to those in the
original biopsy [116].
EBV undoubtedly plays a decisive role in the
genesis of NPC, but it is not yet clear how the virus
becomes associated with the carcinomas cells.
26
B. Nasopharyngeal carcinoma (NPC)
(a) Eidemioloav of NPC
NPC is rare in most countries in the world
[117], with an age adjusted incidence rate of less than
1 per 100,000.
It has been shown that Chinese has high
incidences for NPC [117]. Table 2 shows age-adjusted
incidence rates for NPC in Chinese living in selected
geographical regions.
Table 2. Age-adjusted incidence rates per 100,000 per

















It is apparent that significant difference exist
among Chinese according to their origin. Chinese of
southern origin have' a uniquely high risk, the
incidence rates per 100,000 being 10-20 in males and 5-
10 in females.
(b) Anatomy of the nasopharynx
The nasopharynx, or epipharynx, is an open chamber
situated below the base of the skull and behind the
nasal cavity. It has an irregularly cubic form with six
walls:
(i) Lateral walls
They are symmetric and contain the pharyngeal
orifice of the eustachian tubes, which are small
triangular and infundibular. They are surrounded by the
28
torus tubarius, which is caused by the salience of
cartilage above and behind the opening but not below or
in front of it. A depression may be formed behind it
that is called the recessus pharyngeus (fossa of
Rosenmuller).
(ii) Anterior wall
The anterior wall is formed by the posterior nares
or choanae, oval-shaped openings communicating with the
nasal cavities and separated in the midline by the
nasal septum.
(iii) Posterior wall
The posterior wall lies at the level of the first
two cervical vertebrae and is sometimes continuous with
the roof of the nasopharynx. Laterally, it forms the.
posterior limits of the fossae of Rosenmuller.
(iv) Inferior wall
The inferior wall is a virtual one, formed by the




The roof corresponds to the body of the occipital
bone and to the adjacent part of the sphenoid. It is
almost entirely made up of the lymphoid tissue that
forms the pharyngeal tonsil, or tonsil of Luschka,
which is relatively large in children.
The mucous membrane that covers the nasopharynx is
formed by a ciliated stratified columnar epithelium
that becomes squamous at the oropharynx and at the free
border of the soft palate. Beneath the lining
epithelium there are numerous closed lymphoid
follicles. These lymphoid follicles are particularly
abundant on the rim of the eustachian tube, but they
are present on the lateral and posterior walls as well
as on the nasopharyngeal surface of the soft palate,
where they contribute to form the upper arch of
Waldeyer's ring.
(c) Pathology of NPC
Tumours of the nasopharynx may develop into three
distinct categories: (i) ulcerative, (ii) nodular,
(iii) exophytic. Choa [122] reported that in a group of
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221 cases, 124 were ulcerative (59%), 55 nodular (25%)
and 32 exophytic (15%).
(i) Ulcerative NPC
The ulcerative lesions are most frequently found
on the posterior wall or deep in fossa of Rosenmuller.
Less frequently, they are situated on the lateral wall
in front of the eustachian tube or on the roof of the
nasopharynx. The lesions are small and necrotic. They
usually progressively infiltrate the neighbouring
tissues.
Those that develop on the lateral wall or on the
roof of the nasopharynx are canalized by the pharyngeal
fascia toward the petrosphenoidal region of the base of,
the skull. The foramen lacerum and the foramen ovale
constitute a zone of least resistance and an easy
pathway into the cranium. As the tumours grow, they
tend to enlarge and destroy the foramina and to spread
into the middle cerebral fossa. There they may remain
subdural or may invade, the dura and the bones. In this
area the tumour comes into contact with several cranial




The nodular form of nasopharyngeal tumours arises
most commonly from the eustachian tube area which
becomes rapidly destroyed. The tumour has a grape like,
polypoid appearance and may not show ulceration
anywhere on its surface. The tumour infiltrates around
the eustachian tube and spreads forward. It may extend
into the maxillopharyngeal space and compress the
cranial nerve V. In spreading downward, it may
interfere with the normal excursion of the soft palate
on the side of the lesion. It easily spread to the base
of the skull.
(iii) Exophytic NPC
The. exophytic type of growth is usually a
hemispheric, nonnucleated, sometimes pedunucleated,
smooth tumour that may arise from the roof and may fill
the nasopharyngeal cavity. It pushes the soft palate
downward and spreads toward the choanae and the nasal
cavity. It rapidly reaches the maxillary sinus and the
orbit, producing marked unilateral exophthalmos and
protrudes through the anterior nares.
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(d) Clinical features of NPC
Among patients under 30 years of age, NPC is the
most frequent neoplasm of the upper air passages [123].
It develops without apparent symptoms. Initial nasal
stuffiness and excessive nasal mucus discharge are
nearly always disregarded. Later halitosis, blood-
streaked mucus and poorly localized headache signify
enlargement of the tumour. Epistaxis is not common in
this tumour.
A unilateral painless upper cervical adenopathy is
often the first sign of the disease, the metastatic
nodes usually develop in the submastoid area.
Furthermore, fullness in the ear and hearing loss are
commonly found accompanying with this tumour,
signifying tumour involvement of the eustachian tube.
It may be so insidious that the impairment of hearing
may not have been noticed. A certain number'of patients
will give a history of long-standing unilateral
impairment of-hearing. This is sometimes connected with
chronic inflammatory lesions that may have contributed
to the development of the tumour.
Frequently, pain is a symptom resulting from
compression of the trigeminal-nerve or its branches and
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from invasion of the bones of the skull. The character
of the pain is usually related to the motor function
paralyzes that also result from the compression of the
fifth nerve.
(e) Diagnosis of NPC
Since the development of otolaryngology, NPC have
been more accurately diagnosed in the past 50 years.
However, today there are still many cases pass
undiagnosed. Errors in diagnosis result primarily from
disregard of the pharynx at examination. It has not
been sufficiently emphasized that patients with
cervical adenopathy, particularly those between 30 and
50 years of age may have a primary tumour of
nasopharynx. It is supported by evidence that the
clinical onset of more than half of all primary tumours
of the nasopharynx is characterized by the development
of cervical adenopathy. Even in such cases the delay
between the first manifestation and the diagnosis of
the tumour is six months on the average [124].
(i) Clinical examination
A variety of methods can be applied to examine the
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nasopharynx. A simple method of examination is the
digital exploration. Posterior rhinoscopy, the
examination of the nasopharynx by means of a mirror is
routine in the clinic. A sensory lack in the soft
palate and pharynx should lead to the suspicion that
the vagus nerve is being compressed by tumour.
(ii) Radiographic examination
Radiographic examination is a valuable tool in the
diagnosis of NPC. A lateral and axial projections may
reveal enlargement of the soft tissues of the posterior
wall that had not been suspected on clinical
examination. Roentgenograms of the base of the skull
are of less importance nowadays. Today CT or magnetic
resonance scanning have become the single most
important imaging procedure in evaluation of the extent
of NPC. CT can readily demonstrate involvement of the
parapharyngeal space, the pterygomaxillary fossa, the
infratemporal fossa, the base of the skull, and the
retropharyngeal lymph nodes.
(iii) Laboratory examination
It is well established that 90% of patients with
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undifferentiated NPC have high titres of EBV-specific
IgA against VCA [125). Early diagnosis is possible
because elevated antibody titres to VCA precede
observable clinical symptoms of NPC. Following
treatment, the rise of antibody titres may indicate
recurrence of the tumour.
(iv) Biopsy examination
A biopsy specimen is relatively easy to obtain in
the majority of exophytic NPC., Cytologic study of
nasopharyngeal exudate can establish a diagnosis of
probability of malignant tumours of the nasopharynx.
(f) Histological classification of NPC
According to the classification proposed by the
World Health Organization (WHO) in 1978, three
histological types-- of NPC can be recognized on the
basis of their predominant pattern as seen by light
microscopy:
(1) Squamous-cell carcinoma (keratinizing squamous-cell
carcinoma) (Type I)
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A tumour showing definite evidence of squamous
differentiation with the presence of intercellular
bridges and/or keratinization over most of its extent.
(2) Non - keratinizing carcinoma (Type II)
A tumour showing evidence of differentiation, with
a maturation sequence resulting in cells in which
squamous differentiation is not seen by light
microscopy. The cells have fairly well-defined cell
margins and show an arrangement that is stratified or
pavemented and not syncytial. A plexiform pattern is
present in many tumours. Some may exhibit a clear-cell
structure, due to the presence of cytoplasmic glycogen.
Undifferentiated carcinoma (Undifferentiated
carcinoma of the nasopharyngeal type) (Type III)
The cells in this type of tumour generally have
vesicular nucleic and prominent nucleoli. The cell
margins are indistinct, and the tumour exhibits a
syncytial rather than a pavemented appearance. Spindle
shaped tumour cells, some with hyperchromatic nuclei,
may be present. The tumour cells are arranged in
irregular and moderately well.defined masses and/or in
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strands of logical and histological features are fairly
characteristic and may enable a presumptive diagnosis
of NPC even when identified in metastatic tumours.
(g) Stage classification of NPC
Since the spread of a carcinoma is a continuous
process, it is necessary to classify cancer cases into
groups according to certain stages for the following
purposes:
1. To guide treatment planning.
2. To give some indication of prognosis.
3. To help in the evaluation and comparison of
treatment results, especially those from different
centres.
4. To facilitate cancer research.
In order to achieve the latter two goals, general
agreement on the stage classification to be adopted is
essential. However, a number of stage classifications
of NPC are used, none has yet received general
acceptance. Geist and Portman [126] were the first to
classify NPC into stages. Nevertheless, the
classification is too simple and is suitable for places
where the tumour is encountered only occasionally. In
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1974, the International Union Against Cancer (UICC)
revised a stage classification of NPC [127]. Later the
American Joint Committee for Cancer. Staging and End
Results Reporting [128] recommended another staging of
NPC. The stage classification of NPC generally adopted
in Hong Kong was that recommended by Ho [129]. The
classification is as follows:
r- Primary tumour
Ti Tumour confined to the nasopharynx (space behind
the choanal orifices and nasal septum and above
the posterior margin of the soft palate in the
resting position).
T2 Tumour extended to the nasal fossa, oropharynx or
adjacent muscles or nerves below the base of
the skull.
T3 Tumour extending beyond T2 limits and
subclassified as follows:
T3a Bone involvement below the base of the
skull (including floor of sphenoid sinus).
T3b Involvement of base of skull.
T3c Involvement of cranial nerve(s).
Tad Involvement of orbit or laryngopharynx
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(hypopharynx) or infratemporal fossa.
N- Regional lymph nodes
NO No palpable nodes (excluding nodes thought to be
benign).
N1 Node(s) wholly in upper cervical level, bounded
below by the neck crease extending laterally and
backwards from or just below the thyroid notch...
N2 Palpable node(s) between the crease and the
supraclavicular fossa, the upper limit being a
line joining the upper margin of the sternal end
of the clavicle and the apex of an angle formed
by the lateral surface of the neck and the
superior margin of the trapezius.
N3 Palpable node(s) in the supraclavicular fossa
and/or skin involvement in the form of carcinoma
en cuirasse or satellite nodules above the
clavicles.
The apparent extent of the disease as a whole is
classified into stages:
I Tumour confined to the nasopharynx (Ti, NO, MO).
II Tumour extending to nasal fossa, oropharynx or
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adjacent muscles or nerves below the base of
the skull (T2) and/or N1 involvement.
III Tumour extending beyond T2 limits or with bone
involvement (T3) and/or N2 involvement.
IV N3 involvement, irrespective of the stage of the
primary tumour.
V Haematogenous metastasis and/or involvement of the
skin or lymph node(s) below the clavicles (Ml).
(h) Treatment of NPC
(i) Surgery
Due to the diffusely infiltrating character and
early metastasizing ability of NPC, complete surgical
removal of them is impossible even in cases of early
diagnosis or small size of the lesions. Surgical
lesions are attempted in limited lesions through the
infratemporal fossa.
(ii) Radiotherapy
Most NPC are radiosensitive and theoretically
radiocurable. The difficulty of radiotherapy of these
tumours lies in the administration of a sufficiently
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high dose of radiation throughout the entire area of
primary infiltration and regional involvement. The task
of irradiating,as homogeneously as possible, the deep
seated primary lesion, its possible involvement of the
middle cerebral fossa, its prevertebral first relay of
node involvement, and the cervical metastases, on one
or both sides, requires careful planning of approaches
and doses [130, 131). High doses are required
throughout the nasopharynx and the base of the skull.
However, excessive doses to the brainstem and cervical
spinal cord must be avoided because it may damage the
brain. Endocrine deficiencies related to irradiation of
the pituitary gland and hypothalamus are not uncommon
patients should be monitored closely and treated
promptly for them [132).
A rapid regression of symptoms usually follows the
first administrations of radiotherapy. The impairment
of hearing may disappear, but it may also continue to
the end of the. treatment because of increased edema.
Cranial nerve paralysis of the petrosphenoidal groups
also may diminish or vanish. Pain is usually relieved
after a few weeks of treatment, but in some instances,
probably because of invasion rather than compression of
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the gasserian ganglion, intense pain in the trigeminal
area will persist and will require continuous
administration of narcotics.
The most common complication in the course of
treatments otitis media with its characteristic intense
pain and rapid elevation of. body temperature. This
almost always reacts favourably to the administration
of antibiotics, but hearing may be permanently
impaired.
(iii) Chemotherapy
Patients with recurrent or disseminated NPC are
more likely to respond to chemotherapy than with other
primary site in the upper respiratory and digestive
tracts. Brown et al. [133] reported that among eight
patients treated with vinblastine, bleomycin and
cisplatin, one had complete disappearance and five had
partial-responses. Holoye et al. [134] also reported
three complete responses and one partial response among
six patients treated with combinations of
cyclophosphamide, vincristine, methotrexate and 5-
fluorouracil. Furthermore, they noted that three of
four patients with the diagnosis of lymphoepithelioma
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had complete disappearance of tumour and the remaining
patient responded partially. In The Chinese University
of Hong Kong, combination chemotherapy with cisplatinum
and 5-fluorouracil produced a response rate of about 85
% in lymph-nodal disease [135].
(i) Prognosis of NPC
Radiotherapy is considered as the good prognosis
of patients with NPC. Shu-Chen [136] reported the
results of cobalt-60 teletherapy of 1605 patients from
the National Taiwan University 529 (33%) were alive
five years after treatment. Ho [137] reported a marked
improvement in the proportion alive and well five years
after irradiation between the use of conventional
radiotherapy (1965) and megavoltage radiotherapy the
rate increased from 22% (97 out of 437) to 39% (241 out
of 616). Mesic et al. [138] reported the results of.
megavoltage irradiation that the actuarial disease-free
survival at 5 years for the 251 patients treated was
52%. They noted that differences in radiotherapeutic
technique significantly affected the ability to control
the local tumours. In a report of a clinical study
carried out by the Radiation Therapy Oncology Group,
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Marcial et al. [139] concluded that split-course
irradiation showed no statistically different results
than continuous radiation. Results may be obtained even
with relatively advanced cases [140, 141].
Several efforts have been made to correlate the
immunologic status of the patients with prognosis, but
the results are inconsistent [142]. The stage of
development of the disease is a major factor in
survival. Moench and Phillips [143] reported their 5
years results as follows: Stage I, 16 out of 24 (67%)
Stage II, 25 out of 40 (62%) Stage III, 10 out of 37
(27%) Stage IV, 3 out of 41 (7%). Their overall 5-year
survival was 31%. The presence of cranial nerve
paralysis corresponds to the results. Thomas and Waltz
[144] reported that among 113 patients with neurologic
manifestations, only 9 survived. Involvement of the
bones of the base of the skull seems to darken the
outlook. The presence of distant metastases renders the
patient's prognosis hopeless.
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(j) Etiology of NPC
(i) Dietary factor
In the early 1970s, Ho first suggested that
consumption of salted fish, a traditional Southern
Chinese food especially favoured by the Cantonese,
might be a risk factor for NPC [145]. Since then three
case-control studies conducted among Southern Chinese
populations have investigated such a hypothesis. All
three studies are supportive of the hypothesis. In Los
Angeles, significantly more Chinese patients reported
current consumption of Cantonese-style salted fish
compared to controls [146]. In Hong Kong, Cantonese-
style salted fish was fed to infants during weaning
significantly more often in households with a NPC case
than in control households [147]. In Malaysia,
histories of Cantonese-style salted fish in. childhood
and adolescence were significant risk factors for NPC
in Chinese [148].
A recent case-control study of NPC in Hong Kong
investigated the relationship between NPC and lifelong
dietary habits strongly suggested that childhood
consumption of salted fish was the primary cause of NPC
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in that Cantonese population. Yu et al. estimated that
over 90% NPC cases in Hong Kong Chinese could be
attributed to intake of this food during childhood
[149].
A number of experimental investigations have
implicated the presence of potential nasopharyngeal
carcinogens or their precursors in Cantonese-style
salted fish. Several volatile nitrosamines, which have
found to be potent inducers of nasal cavity tumours in
animals [150, 151, 152], have been detected in samples
of salted fish [153, 154]. More significantly, rats fed
salted fish have been shown to pass mutagenic urine
[155] and to develop carcinomas of nasal cavity [156].
Last year Yu et al. reported a case-control study
of preserved foods and NPC in Yulin Prefecture of
Guangxi Autonomous Region [157]. Guangxi was selected
because it had a second highest mortality rate of NPC
of all Chinese provinces (Guangdong had the highest
mortality rate of NPC) and consisted of a non-Cantonese
population. They found that the level of salted fish
consumption in this study population was relatively
low. Since Southern Chinese diet contains a variety of
salt-preserved and fermented, foods, they began to
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speculate that childhood intake of other preserved
foods besides salted fish may also be related to NPC in
Southern China.
They reported that the study further confirmed the
association between salted fish intake and risk of NPC
in Southern China. They observed significant
associations between NPC and consumption frequency
during pregnancy, nursing and weaning. Besides salted
fish, exposure to other salt-preserved and fermented
food products is also related to an elevated risk of
NPC in the study population. Independent and
significant association with early (prior to age 2
years) consumption of dried fish, salted duck eggs,
salted mustard green, chung choi and fermented soy bean
paste.
Poirier et al. [158] recently analyzed samples of
salted mustard green, chung choi and fermented soy bean
paste for volatile nitrosamines. One or more volatile
nitrosamines were detected in all three foods, However,
as in the case of salted fish, it is not clear yet
whether any of the volatile nitrosamines detected in
these fermented foods are directly involved in the




The high rates of Southern Chinese both in China
and abroad and intermediate rates among populations
admixed with Chinese have suggested a primary genetic
cause [159]. The finding of a significant association
between HLA-A2 and less than two antigens at the.-B
locus and NPC in Chinese supports this hypothesis [160,
161, 162].
Simons et al. [162] reported that HLA antigens
play a role in determining both susceptibility for NPC
and survival after diagnosis. The distribution of both
locus A and locus B antigens is very significantly
different'in newly diagnosed NPC patients as compared
to the normal population. Moreover, significant
differences also emerged between long-term. survivors,
and newly diagnosed cases.
Among the Chinese, there are two locus B antigens,
B-Sin 2 and BW17, that are associated with
susceptibility for NPC. When attention is confined to
newly diagnosed NPC cases, it has been shown that apart
from the increased risk associated with the joint
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occurrence of A2 and B-Sin 2, there is also an
increased risk associated with BW17. Furthermore, the
association of HLA A2- HLA B-Sin 2 is stronger in more
severe cases, judged by shorter survival time, and in
those over the age 30 years. Simons et al. have
postulated that this association, may be due to linkage
disequilibrium with a specific disease susceptibility
or immune-response gene at or near the HLA-D locus.
Subsequent studies among Chinese in Singapore
[163], Malaysia [164], Hong Kong [165], People's
Republic of China [166] and California [167] further
confirmed the hypothesis.
However, Chinese migrants to Hawaii and California
have a decreasing rate in succeeding generations that
cannot be accounted for on the basis of genetic
admixture [168]. Most importantly, there is an
increased risk of NPC among low risk racial groups born,
and raised in high risk areas: California whites born
in Southeast Asia [169] and Jews born in Asia or North
Africa [159]. Therefore besides genetic susceptibility,
other factors such as environmental factors should be
accounted for the causation of NPC.
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(iii) Environmental factors
Many toxic metabolites of Streptomyces including
antibiotics and fermentation products from fungi have
been screened for EBV inducing property using the
synergistic assay method designed by Ito et al. [75].
So far teleocidin and its related compounds were the
only group of such substances to give a positive
reaction. This finding is important because tumour
promoters determined by the synergistic assay method
can be placed into two categories:
(1) Plant diterpene esters:
Active principles from the Euphorbiaceae and
Thymelaeaceae families (eg. TPA from Croton tiglium).
(2) Microbial indole alkaloids:
eg. Teleocidin from Streptomyces.
If the age-standardized mortality rate for NPC in
China were mapped province by province and compared
with the distribution of the Croton oil tree and other
related plants, a striking similarity between the two
distribution patterns was observed [170]. Moreover, a
search for EBV-activating plants in the NPC endemic
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areas was conducted. Over 60 plants belonging mostly to
the Euphorbiaceae,and some to the Thymelaeaceae grow in
the area and are currently used as local folk
medicaments.
A new aspect of plants containing EBV activators
is A. fordii. It is a medicinal plant and also has
important industrial uses. It is widely cultivated in
Southern China and its province by province
distribution almost overlaps that of the croton oil
tree [171].
In Southern China and also in south-eastern
Asiatic countries, fresh tung oil is frequently used
for polishing, preserving and water-proofing wood used
in the interior of houses and living compartments of
boats and'ships. This suggests a possible link with the
reported high incidence of NPC among boat dwellers in
Southern China [172].
Plantations of tung oil trees can be seen along
the main roads- in the southern provinces of China,
particularly near the villages and around the houses.
Such a situation constitutes a local environment likely
to be rich in EBV-activating substances derived. from
the Tung oil plant.
52
The people living in areas with numerous plants
containing EBV-activating and tumour-promoting agents
may come in contact with the agents in the following
ways:
(1) Intake as herbal drugs
(2) Inhalation of volatile fractions of the oil
(3) Inhalation of pollens from flowers of the plant
(4) Inhalation of dust derived from soil in which such
active. substances from the plants was released [171].
Soil samples were collected from under Chinese
tung oil trees in NPC endemic areas and these samples
yielded EBV-activating ether extracts [173].
Presently, it is considered that repeated exposure
for a prolonged period to soil dust containing active
substances fits well with the EBV activator and tumour
promoter theory relating to the etiology of NPC.
Hothesis for etiology of NPC
The opportunistic growth of microbes that produce
EBV-inducing fatty acids in the surrounding of Southern
Chinese has been shown. by isolation of such bacterial
species from the tumourous regions in the nasal cavity
of NPC patients. On the other hand, epidemiological
data suggesting the presence of preceding nasal illness
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as a high risk factor for NPC are also reported [174].
With these data and the promoter property of diterpene
esters, Ito proposed a hypothesis for the etiology of
NPC.
He postulates that an endogenous factor such as
microbial fatty acids in the nasal cavity act
synergistically with exogenous substances, the
diterpene esters, which may reach the
'microenvironment' in the mucous membrane of the
nasopharynx via the routes previously described. If
such exposure continue for a prolonged period of time,
the occurrence of NPC in the later stage of life among
people living in the high risk areas could be accounted
for. This hypothesis is illustrated in Fig. 3.
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To assess the hypothesis, attempts were made to
mimic such a situation in vitro. Non-producer Raji
cells were exposed to culture fluids of Fusobacterium
nucleatum isolated from the human oral cavity together
with ether extracts of Croton tiglium and Euphorbia
lathyris. Both new isolates and-the standard laboratory
strains of F. nucleatum efficiently enhanced the
expression of EBV EA in the Raji cells [175].
(iv) Other factors
Several case-control studies have been conducted
to find risk factors associated with NPC. Yu et al.
reported that living with a smoker during childhood was
positively associated with NPC [157]. There was a
significant trend in risk of NPC with the number of
cigarettes smoked per day by the father. Volatile
nitrosamines have been detected in tobacco smoke [176]...
However, a study in Hong Kong showed that childhood
exposure to household tobacco smoke was not a risk
factor for NPC [149]. Further investigations are needed
in this aspect.
Many case-control studies have examined the
possible role of prior ear or. nose conditions in the..
56
development of NPC, and most have observed an
association [177, 174, 157]. It is difficult to be
certain whether the presence of disease of the nose and
ear is a predisposing risk factor or whether it is
secondary to the same common etiological agent(s).
The relationship between NPC and use of nasal oil,
of which the main ingredients are camphor and menthol,
has been investigated in a number of studies. In Taiwan
[178] and in Singapore [179], use during adulthood was
associated with an elevated risk of NPC. In Hong Kong,
a significant risk was also observed [149].
Besides tobacco smoke, other sources of inhaled
smoke, including incense and anti-mosquito coils, have
also been extensively investigated. None of the studies
has reported significant association with NPC.
Moreover, other studies have not found people in




Although cancer is an old disease, the awareness
of carcinogenic agents and the implication of
environmental factors in the causation of the disease
are relatively recent.
Among the suspected environmental carcinogens,
radiation has received much attention. Ionizing
radiation is present and is increasing in our
environment, and in recent years public attention has
focused on the hazards of the low dose range, doses
used in medical diagnosis. Although it is a weak
carcinogen as compared to some chemicals, ionizing
radiation is present everywhere and measurable at low
doses.
Radiation of the electromagnetic spectrum for
which carcinogenicity has been established include
ultraviolet rays and ionizing rays (Roentgen rays and
gamma rays) [180]. Other ionizing radiations with
carcinogenic potency include the particulate radiations
such as alpha particles, beta particles, neutrons,
protons.
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The types of neoplasms resulting from ionizing
irradiation depend on the dose of radiation, age at
exposure, sex and other factors. After irradiation of
the whole body or trunk in the dose range below 1000
rad, the neoplasms that have been demonstrably
increased in frequency among adults within the first
25-30 years after exposure include various leukemias
and cancers of the female breast, thyroid gland,
bronchus, stomach, salivary gland, other
gastrointestinal tract organs and lymphoid tissues.
Nonionizing ultraviolet (UV) radiation has been
associated with skin cancer in humans [181]. It has
been reported that besides genetic factors and complex
environmental cofactors, the risk following exposure to
sunlight varies with life-style, climate, altitude, and
pollution, where photochemical oxidants serve as
additional modifiers [182].
(b) Viral Carcinogenesis
Viruses were shown to be oncogenic agents as far
back as the early 1900's and have proved extremely
useful tools not only for investigating the malignant
character of infected cells but also in dissecting the..
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basic physiology and genetics of their hosts [183].
The number of potential human oncogenic viruses,
however, is far fewer than the number of animal viruses
that are capable of tumour induction in experimental
animals. The human adenoviruses (Ads) are the first
human tumour viruses to be described in 1962 Ad12 and
Ad18 were shown to induce tumours in newborn hamsters
[184, 185]. They commonly cause respiratory and other
infections in children and adults, frequently become
latent in lymphoid tissues, and persist for long
periods often without recurrent illness.
Most humans are infected early in life by several
of the common human Ads. Since ads have oncogenic
properties, it is possible that they are involved in
human cancer. Although there is no direct evidence that
cancer occurs as a result of virus infection, or from
an infectious disease, or in epidemics, a viral,,
etiology of cancer is conceivable.
A rare abortive Ad infection early in life could
result in the integration of Ad transforming gene(s)
into a cell chromosome. However these may remain
dormant and not be expressed for some reasons, possibly
one associated with the hormonal balance or the immune
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system of the individual. At later stages of life when
these systems undergo modifications associated with
aging or perhaps bombardment by environmental
carcinogens, the Ad transforming gene(s) could be
induced, transforming proteins could be expressed, and
cancer could develop. If such an Ad etiology of cancer
exists, then tumours should contain Ad DNA representing
transforming genes and probably other genes.
There are two types of herpes simplex viruses.
Type-1 herpes simplex virus (HSV-1) which infects the
oropharyngeal pathway, and type-2 herpes simplex virus
(HSV-2), which infects the genital tract, are
distinguishable but not totally different antigenically
[186]. Data have also been presented suggesting an
association between HSV-1 and squamous cell carcinomas
of the head and neck [187].
EBV, one of herpesviruses, is associated with..
Burkitt's Lymphoma and NPC. However there are not
enough similarities between these cancers and carcinoma
of the cervix to serve as a strong argument for or
against the role of herpes simplex virus.
Extensive studies of the role of viruses in cancer
have been performed in the past decade. To date, the..
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interactions of human pathogenic viruses in oncogenesis
can be outlined into four categories.
The first group of viruses are found to insert the
viral genome into host cell nucleus and persist there.
THe expression of at least one viral function seems to
be a requirement for maintenance of the transformed
state. Majority of tumour viruses belongs to this
group examples of them are Hepatitis -B,
papillomaviruses, EBV and HTLV1.
Another group of viruses are mainly the herpes
simplex viruses. Abortive infection by this group of
viruses modifies the host cell DNA [188, 189]. In
contrast to the group just mentioned, transformation of
rodent cells by these infections does not require
persistence of the viral DNA. It has been suggested
that the induction of selective DNA amplification by
these agents may play an important• role in.
transformation [190]. Besides herpes simplex viruses,
another 'member .of the herpesvirus group, psuedorabies
virus, has been found to have this property.
The third group are viruses causing the
threatening disease, the acquired immunodeficiency
syndrome (AIDS). In this case, immunodeficiencies are
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induced by the agents and development of specific types
of tumour occurs without directly related to the AIDS
virus infection.
The last group consists of viruses inhibiting
oncogenicity. There is evidence suggesting that these
viruses interact with infected host cells in early
events, possibly initiation process in carcinogenesis
[190]. An example of these viruses are parvoviruses.•-
Since the majority of tumour viruses belongs to
the group which insert their genetic material into the
host cell, it is worthwhile to discuss them in more
detail.
All carcinomas developed as a consequence of these
viral infections have some common features:-
(1) They are monoclonal tumour
(2) Long latency period elapse before they develop
(3) Only a small percentage of infected individuals.
eventually develops carcinoma.
(4) Expression of the persisting viral genome seems to
be confined to a specific set of genes.
Papillomaviruses have been used as tools in
studying the mechanism of cancer induction following
these infections. From the results of studies-of HPV in
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cervical cancer, zur Hausen suggest the existence of an
intracellular surveillance mechanism which controls
papillomavirus infections. He proposes that the
development of human cancer is a result of failing
host-cell control of persisting viral genes [191, 192,
193]. This proposal can readily explain the long
latency periods between primary infections of cancer-
linked viruses and the appearance of cancer. It also
provides an explanation for the fact that only only a
small number of infected individuals develops cancer.
(c) Chemical Carcinogenesis
In the past twenty years, awareness and concern
about the role of chemicals in the origins of human
cancers have become prominent. Detecting, identifying
and defining those chemicals capable of causing cancer
have become major aims in toxicology.
Traditional toxicology has been concerned mostly
with toxic effects having the following
characteristics: (1) They appear early (2) the
intensity of the*' induced pathology is directly
correlated with the intensity of the toxic exposure
and (3) manifestations of toxicity are due to altered
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functional products, degenerative changes, or death of
the target cells themselves. Saffiotti refers to these
as terminal toxic effects [194].
The traditional approach for estimating an
acceptable for human exposure to agents inducing such
terminal toxic effects has- been that of using
relatively short-term animal toxicity tests,
determining a no-effect level under the conditions .of
test, and then applying a so-called safety factor for
extrapolation to the human situation. If these
estimations still turn out to be excessive for humans,
as evidenced by the consequent development of toxic
symptoms, then exposures can be further reduced until
the symptoms disappear. This approach implies that the
symptoms indicating toxicity should appear early and
that the damage should be reversible.
These traditional methods in toxicology are,
inadequate to deal with the pathogenetic mechanisms
involved in the chemical induction of cancer. The
characteristic toxicologic event in carcinogenesis is a
trigger change in the target cell's regulatory
mechanism, which determines a self-replicating cell
lesion. The carcinogenic event so modifies the genomes
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and/or other molecular control mechanisms in the target
cells that these are then able to give rise to a
progeny of permanently altered cells. It is indeed this
progeny of cells which represents the induced
pathology. The expression of the toxic injury therefore
does not derive from the same cells that were
originally hit by the toxic agent, or from their
functional products, but rather from the proliferation
of a new population of altered cells
The subsequent growth of the altered cell
population into a clinically detectable neoplasia
follows the rule of biological determination. In this
respect, carcinogenesis fits well, at the somatic-cell
level, into the general pattern of biological evolution
defined by Jacques Monod as a sequence of chance events
followed by the necessity of biological determination
of their expression [195, 194].
The critical molecular injury caused by specific
carcinogenic agents may be quantitatively extremely
limited, even to a few cells, and may therefore remain
silent. What will make it manifest is the proliferation
of the altered cell population, the extent of which is
dependent on host conditions. The intensity of the
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pathological response in a subject, the growth rate and
spread of a cancer, is not dependent on the level of
carcinogenic exposure received by the subject. In fact,
each tumour is characterized by independent
progression.
Carcinogenic effects are therefore intrinsically
different from the terminal toxic effects described
above. The characteristics of carcinogenic effects are
the following: (1) Their appearance is delayed (2) the
frequency of the expression of injury, eg., tumour
incidence, in the exposed population is directly
correlated with the intensity of exposure, but the
intensity of the induced pathology, eg., tumour growth
and spread, is independent of the intensity of the
carcinogenic exposure and (3) the manifestations of
toxicity are due to the proliferative response of a new
altered cell population. Saffiotti refer to these.
effects as self-replicating toxic effects [194].
Chemicals s-that can induce self-replicating toxic
effects may also induce terminal toxic effects, and the
two types of induced pathology.should be kept distinct.
Volatile nitrosamines are a well known group of
chemical carcinogens. A number of studies have shown.
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that they can induce tumours in animals [196, 197, 198,
199].
Several chemicals are found to be closely
associated with different types of cancers. These are
summarized in Table 3.
Table 3 Landmarks in the recognition of chemical
carcinogenesis
ReferencesCancerChemicals
Aromatic amines [200, 201, 202]Bladder







Experimental evidence that non-carcinogenic agents
could enhance tumour yield in response to a carcinogen
was first obtained when tar painting on mouse skin was
followed by mechanical wounding. Subsequent studies
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demonstrated the same effect with a chemical agent, oil
extracted from Croton tiglium [209]. The active
constituents of croton oil have been identified as
phorbol esters, of which the most potent is 12-0-
tetradecanoyl-phorbol-13-acetate (TPA).
Agents that induce tumours only when administered
after a carcinogen are called promoters.
Tumour promotion has been most extensively studied
in mouse skin [210, 211]. It has been established that
treatment with a carcinogen, referred to these
circumstances as an initiator, at a dose not in itself
sufficient to induce tumours, will nevertheless lead to
tumours if followed by repeated doses of a promoting
agent.
Initiation appears to be an irreversible and rapid
event [212] the start of promotion can be delayed for
as long as a year without any diminution in the.
eventual tumour yield. In contrast, promotion is a slow
protracted process that is to some extent reversible
multiple treatments with the promoting agent are
required for many' weeks and. tumours will fail to
develop if the time gaps between treatments are too
long. The sequential nature of the process is-indicated
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by the fact that if the promoter is administered before
the initiator, no tumours develop [213]. The two-stage
carcinogenesis of mouse skin is summarized in Fig. 4.
Fig. 4 Protocol for two-stage carcinogenesis in mouse
skin.
(I= single treatment with an initiating agent P=






HighPI (1 yr. interval)
0- P (intermittent)I
When a chemical carcinogen is applied repeatedly
to mouse skin, the usual types of tumours produced are
carcinomas, According to the two-step initiation-
promotion hypothesis, the chemical agent is acting as
both an initiator and a promoter in these
circumstances. When a single, dose of initiator is
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followed by repeated doses of a promoter, the tumours
produced are mainly benign papillomas, a few of which
subsequently progress to malignant carcinomas. However,
If the papillomas are treated with a second dose of
initiator, a large proportion of them becomes
malignant.
In addition to mouse skin, other mammalian tissues
are susceptible to the promotion of tumours by phorbol
esters (Table 4).
Table 4 Tumour promotion by phorbol esters in tissues







Glandular stomach Rat [218]
ManOesophagus [219]
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(ii) Tests of chemicals for carcinogenic activity
A number of methods have been devised for the
bioassay of carcinogenic agents found in our
environment. Although whole-animal bioassay procedures
are the basis of determining the potential risk of the
chemical for the development of cancer in humans, the
testing of all potentially dangerous chemicals by
whole-animal bioassays would be physically and
financially impossible. Thus considerable effort has
been directed toward devising screening methods of
bioassay that may indicate which chemicals can be
potentially dangerous. A summary of these short term
tests for carcinogenicity and mutagenicity is shown in
Table 5.
Table 5 Short-term screening tests for carcinogenicity
and mutagenicity.
End-PointTest
Back or forward mutations inProkaryote mutagenesis
specific bacterial strainsin vitro (eg. Ames test)
(with added liver homoeenate)
Back or forward mutations inHost-mediated prokaryote
specific bacterial strainsmutagenesis in vivo
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Mutagenesis in cultured Scoring of dominant or linked
mutationscells
Scoring of mutationsMutations in Neurospora
Mitotic recombination in Conversion of heterozygous to
homozygous stateyeast alleles to
homozygous state
Recessive lethal testDrosophila
Induced chromosomal Visible alterations in
aberrations-. karotype
Appearance of micronuclei inMicronucleus test
bone marrow cells in vivo
Visible exchange of labeledSister chromatids
differentially exchanged sister chromatids
Unscheduled DNA-synthesis orDNA repair in vivo or
DNA strand breaksin vitro
Altered fidelity of DNAFidelity of DNA
synthesis in cell-freepolymerase in vitro
system
One of the most popular screening assays of this
type is the Ames test. Since most carcinogenic
chemicals are mutagenic per se or are metabolized in
vivo to mutagenic compounds, the Ames assay, which
depends on the induced mutation of one or more highly
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mutable bacterial strains, is a reasonable procedure
for carcinogenicity.
A specific strain of bacteria, usually salmonella,
the test chemical, and a mammalian tissue extract
(commonly of rodent liver) are mixed with soft agar
containing a trace amount of histidine (to allow
limited growth and expression of mutations). This
mixture is spread on a. layer of hardened agar in a
Petri dish. The dish and its contents are incubated for
48 hours. If mutagenic, the chemical or its metabolite
resulting from the action of the liver extract reacts
randomly with bacterial DNA. When this occurs at or
near the original mutation site, a second (or reverse)
mutation results, converting the histidine gene back to
its normal structure. The second mutation allows the
bacteria to synthesize histidine again de novo,
resulting in visible growth of revertant colonies on-
the Petri dish.
Comparing with Ames test, the synergistic assay
system proposed by Ito,,et al. [75] is more time saving
and simpler.
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D. Selenium and cancer
The role of selenium in nutrition has been studied
for many years. The element is widely distributed in
nature, small amount being present in the water, soil
and in our food. However, the amount varies in
different geographic areas. In regions where levels are
high, animals have developed selenium toxicity.
Consequently, much of the early studies involved its
toxicology, and there is no doubt that the ingestion of
excessive amount is toxic to both animals and humans
[220].
However, it has been shown to be an essential
element. The suggested intake for adult humans is about
50-200 ug, according to the Recommended Dietary
Allowances proposed by Food and Nutrition Board in the
U.S.A. [221].
Selenium has also been linked to cancer.
Initially, studies were reported suggesting that it is
a carcinogen in animals. The evidence, however, is
scanty and inconclusive.
On the other hand, Shamberger and Frost [222]
suggested that cancer mortality rates in the United
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States were inversely associated with the geographic
distribution of selenium. Shamberger and Willis [223]
then proceeded to show a strongly inverse association
of blood selenium level and cancer mortality. They
found that mortality due to cancers of the lung,
breast, gastrointestinal tract and peritoneum, as well
as lymphomas, was higher in regions of the United
States that could be classified as low in selenium -on
the basis of the typical selenium contents of locally
produced forage crops. A number of epidemiological
studies supported that a lower incidence of cancers was
found to exist in areas where higher levels of selenium
are normally consumed [224, 225].
Furthermore, addition of selenium as selenite to
the drinking water significantly reduced the incidence
of virus (MuMTV) -induced mammary tumours in mice
[226, 227]. Similarly, numerous reports had -shown that.
dietary supplementation of selenium prior- to or
concurrently with carcinogen administration lowered the
incidence of various malignant tumours in rodents [228,
229, 230]. These data suggest that selenium- may have a
preventive role in the etiology-of cancer.
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III METHODS AND MATERIALS
A. Induction of EBV EA in Raji cells by Chinese
medicinal herbs
(a) Extraction of Chinese medicinal herbs with ether
10 grams of eacn cninese meaicinal. nerd was cut
into small pieces and extracted with 100 ml of ether
under reflux for 72 hours. The etherial solution was
then evaporated and the residual oily extract was used
as the test substance. Finally the extract was
dissolved in 100 ml of absolute ethanol as 100 mg/ml
stock solution and was stored at -200C.
Both the diethylether and absolute ethanol were
purchased from Riedl-de Haen, Federal Republic of
Germany.
(b) Extraction of Chinese medicinal herbs with water
5 grams of, each test material was cut into small
pieces and extracted with 50 ml of double distilled
water. After boiling for 30 minutes and centrifugation
at low speed, the supernatant was collected and was
stored at -200C as 100 mg/ml stock solution.
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(c) Extraction of formulae of Chinese traditional
medicines and patent medicines
For each formula of tonic, a total of 20 grams was
weighed and extracted with 200 ml of ether and stock
solution was prepared as previously mentioned. For
water extract, 10 grams was weighed and extracted with
100 ml of double distilled water and stock solution was
prepared as previously mentioned.
For each formula of purgative herbs, each herb was
weighed according to the formula. Water extract and
ether extract were prepared as previously mentioned.
Each patent Chinese medicine preparation was
ground into powder and extracted as previously
mentioned.
All-the Chinese medicinal herbs, traditional and
patent medicines were purchased from Yue Wah Company
and On Hong Ling Pharmacy in Hong Kong.
(d) Extraction.of Cantonese preserved food items with
ether
Approximately 10 grams of each food sample was cut
into small pieces and extracted with 100 ml of ether
under ref lux for 72 hours. The ether .was then
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evaporated and the oily residue was then dissolved in
100 ml of absolute ethanol as stock solution and stored
at -200C.
(e) Inactivation of Foetal bovine serum
When foetal bovine serum .was received from the
supplier, it was heat inactivated at 560C for 30
minutes and was then stored at -200C for future use.--
The foetal bovine serum was purchased from Flow
Laboratories, Australia.
(f) Preparation of RPMI 1640 complete medium
The RPMI_ 1640 powder was dissolved in
approximately 900 ml double distilled water. 26.7 ml of
sodium hydrogen carbonate solution (7.5% w/v) was then
added to the medium. The pH of the medium was adjusted
to 7.5 by addition of 1 N hydrochloric acid-and double.
distilled water to final volume of 1 litre.
The medium was then filtered immediately by 0.22
um membrane filter with air pump. After filtration, 10
ml of penicillin'- streptomycin solution (10,000
units/ml penicillin G sodium, 10,000 ug/ml streptomycin
sulfate) and 5 mg of sterilized.fungizone solution were
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added.
Finally, to 85 ml of the medium, 15 ml of
inactivated foetal bovine serum was added and this
complete RPMI 1640 medium was stored at 40C.
The RPMI 1640 was purchased from Sigma Chemical
Co., U.S.A. The sodium hydrogen carbonate and
hydrochloric acid were purchased from E. Merck, Federal
Republic of Germany. The penicillin- streptomycin was
obtained from Gibco Laboratories, U.S.A. and the
fungizone was purchased from Squibb Co.
(g) Preparation of sodium butyrate solution
0.8807 gram of sodium butyrate was weighed and
dissolved in 100 ml of RPMI 1640 medium. It was then
filtered-by 0.22 um membrane filter and stored at -200C
as 80 mM stock solution.
The sodium butyrate was purchased from. E. Merck,,
Federal Republic of Germany.
(h) Preparation of Phosphate-buffered saline (PBS)
80 g sodium chloride, 11.45 g disodium hydrogen
phosphate, 2 g potassium chloride and 2 g potassium
dihydrogen phosphate were dissolved in 1 litre of
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double distilled water and was kept at room temperature
as stock solution. Ten fold dilution was made when it
was used.
The sodium chloride, disodium hydrogen phosphate,
potassium chloride and potassium dihydrogen phosphate
were purchased from E. Merck, Federal Republic of
Germany.
(i) Preparation of sodium selenite
40 mg of sodium selenite (s) was dissolved in 100
ml of RPMI 1640 medium. It was then filtered by 0.22 um
membrane filter and kept as 400 ug/ml stock solution at
-20°C.
The sodium selenite was purchased from BDH Ltd.,
England.
(j) Cultivation of Raji cells
The EBV genome-carrying human lymphoblastoid Raji
cells were stored in cryo-tubes in liquid nitrogen when
not in use. Raji cells were thawed from liquid nitrogen
and immediately transferred to 370C water bath. When
completely dissolved, the cell suspension was
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transferred into a pre-cooled 50 ml tube.
RPMI 1640 medium was added very slowly into the
tube and shaking it gently at the same time. After 10
ml of the. medium had been added, the Raji cells were
pelleted by centrifugation at 1200 r.p.m. for 10
minutes. The supernatant was removed and the cells were
washed twice with the medium. The cell suspension with
25 ml of medium was transferred to a 275 ml culture
flask and was put into 5% CO2incubator at 370 C and
cultivate for future use, changing the medium when it
was needed.
(k) Harvesting of Raji cells
When Raji cells were needed for experimental use,
the cell suspension were collected from the CO2
incubator. Raji cells were then pelleted by
centrifugation and resuspended in'RPMI 1640.medium. To
assure optimal condition of culture, viability of the
cells was checked with trypan blue. The minimum
acceptable viability was 70%.
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(1) Culture of Raji cells with test substances
Raji cell suspension in RPMI 1640 medium with 15%
foetal bovine serum was added to each well of 24 wells
culture plates and followed by addition of sodium
butyrate. Test substance was then added at varying
concentrations. The final density of the cells was 1 x
106/ml and the concentration of sodium butyrate was 4mM.
The varying concentrations of ether extracts of Chinese
medicinal herbs were 1000 ug/ml, 100 ug/ml, 10 ug/ml
and 1 ug/ml the concentrations of water extracts were
10 mg/ml and 5 mg/ml. For each Chinese food item,
concentration of 10 mg/ml, 1 mg/ml, 0.1 mg/ml and 0.01
mg/ml were used.
The test substances at the varying concentrations
were also added to Raji cell suspension in medium
without butyrate.
Croton oil was used as positive control.and it was
added at varying concentrations. A negative control was
made by culturing the cells with 4 mM butyrate in RPMI
1640 medium. For the two controls, Raji cell suspension
was also added without butyrate.
The 24 wells culture plates were then incubated in
a humidified atmosphere of 5% CO2 at 370C for 48 hours.
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The croton oil was purchased from Sigma Chemical
Co., U.S.A.
(m) Preparation of smears
After culturing for 48 hours. The cells were
pelleted by centrifugation and washed two times with
phosphate-buffered saline (PBS). The viability of the
cells was checked again by trypan blue (The sample
would be discarded if the viability was below 70%).
After washing with PBS, the cell density was
adjusted to 1x106/ml and 25 ul of each sample was added
to each well of of 12 wells slides. The slides was then
allowed to be air dried. After they were completely
dried, the slides were fixed in acetone at room
temperature for 10 minutes. They were then stored at
-700C.
The. acetone was purchased from E. Merck, Federal
Republic of Germany.
(n) Staining of to by indirect immunofluorescence
method
The slides were collected from the freezer at
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-70° C and were washed two times with PBS for 10
minutes. After a 20 fold dilution, EBV-positive serum
(EA titre 1: 1280) from patients with NPC was added to
each well.
For the purpose of comparison, serum from a
healthy donor (EA titre 1:5) was added to a well
prepared from cells incubated with croton oil and
sodium butyrate.
After addition of sera, the slides were incubated
at 37°C for 30 minutes. They were then washed two times
with PBS for 10 minutes. A 1:40 dilution of fluorescein
isothiocynate-conjugated rabbit immunoglobulins to the
gamma chain of human IgG (FITC) was added to each well
and the slides were incubated at 37°C for 30 minutes.
The slides were then washed with PBS two times for
10 minutes and the slides were mounted in 90% glycerol
in PBS. The wells were examined with a fluorescence
microscope. For each well, at least 500 cells were
counted and the percentage of fluorescent cells was
recorded. If the percentage of the negative control was
greater than 0.1, the experiment would be repeated.
The FITC was purchased from Dakopatts, Denmark.
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B. Repeated exposure of Raji cells to Chinese
medicinal herbs
Among the Chinese medicinal herbs found negative
in the present study after culturing for 48 hours, 20
of them were selected to perform the repeated exposure
experiment.
Raji cells were cultured with 4 mM sodium butyrate
and varying concentrations of each herb: 1000, 100, 10,
1 ug/ml as mentioned in A(l). After 48 hours of
exposure, the cell suspension in each well was
collected and pelleted by centrifugation. Then the same
varying concentrations of each herb and 4 mM sodium
butyrate were added to the pellets in corresponding
tubes. They were well mixed and transferred to each
well of culture plate and incubated for another 48
hours.
After the two days, 0.1 ml of cell suspension in
each well was collected and assayed for EA positive
cells' as already mentioned. The other portion (1.9 ml)
of cell suspension 'left in each well was collected and
pelleted. Then the same varying concentrations of each
herb and 4 mM sodium butyrate were added as before.
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they were incubated again for another 48 hours.
The procedures were repeated three more times
making the total incubation time to 10 days.
C. Effect of sodium selenite on induction of EBV-EA
Daphne genkwa, the strong EBV inducer found in the
present study, was chosen to study the effect of sodium
selenite on EBV activation.
Varying concentrations of sodium selenite were
added to culture wells containing Raji cells, sodium
butyrate and varying concentrations of the ether
extract of Daphne genkwa: 20 ug/ml, 40 ug/ml, 60 ug/ml,
80 ug/ml and 100 ug/ml. The final density of Raji cells
was 1x106/ml and the concentration of sodium butyrate
was 4mM. For each concentration of Daphne genkwa, the
following concentrations of sodium selenite.were added:
0.25, 0.50, 0.75, 1.00, 1.25, 2, 3, 4, and 5ug/ml.
Control culture was prepared by culturing Raji
cells with 4mM butyrate and the varying concentrations
of Daphne genkwa.
Parallel assays were carried out with the varying
concentrations of sodium selenite under similar
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conditions of culture in the absence of Daphne genkwa
to check the cytotoxic effect of sodium selenite. The
growth rate of Raji cells in sodium selenite-containing
culture media was expressed as the percentage of cells
in the untreated control culture (without selenite).
The viability of cells was determined by the trypan
blue method.
D. Lists of test substances
A total of 72 single herbs, 8 formulae of tonics,
4 patent medicines, 5 purgative formulae, and 16
Cantonese preserved food items were tested. All test
substances are listed below (see Appendix for names in
Chinese).















Leguminosae 12. Astraglus hoantchy
13. Glycyrrhiza glabra
Leguminosae 14. Phaseolus calcaratus
15. Euchresta japonica
Campanulaceae 16. Platycodon grandiflorum
17. Codonopsis pilosula
18. Adenophora verticillata
Liliaceae 19. Smilax glabra
20. Polygonatum officinale
21. Fritillaria thumbergii
Scrophulariaceae 22. Rehmannia glutinosa
23. Herpestris monniera
24. Scrophularia oldhami
Orchidaceae 25. Gastrodia elata




Compositae 28. Cirsium japonicum
29. Atractylis ovata
30. Saussurea lappa
Thymelaeaceae 31. Daphne genkwa
32. Stellera chamaejasme
33. Aquillaria agallocha











































(b) Formulae of tonics
Chinese name of the formulae
73. Ching po leung
74. Ya say mei
75. Ng fa char







Dioscorea batatas, Nelumbo nucifera, Lilium brownii,
Poncirus trifoliata, Polygonatum officinale, Yuen yuk
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Kam wo char:
Agastache rugosa, Lean Yip, Bu Ja Yip, Liquorice, Siler
divanicatum, Scutellaira Baikalensis, Trichosanthes
kivilonii, Shan Chi, Lonicera japonica, Kon Kot, Hong
Yu, Tam Jok Yip, Artamisia Apiacea, Perilla frutescens,
Platycodon grandiforus, Prunus persica, Atractylis, Men
Yen Chan, Wu Yok, Dung Song, Ku Dun Char, Allsma
planta, Bin Long, Peppermint, Clematis chinensis,
Forsythia suspensa, Hedychium coronarium, Crataegus
cuneata, orange peel, Coptie chinensis.
Pat tsun:
Rehmannia glutinosa, Paeonia albiflora, Codonopsis
pilosula,. Conioselinum univitatum, Atractylis ovata,
Glycyrrhiza glabra, Poria cocos.
Ton liu:
Astraglus Hoantchy, Codonopsis pilosula, Dioscorea
batatas, Lycium chinense.
Sep chuen:
Rehmannia glutinosa, Paeonia albiflora, Codonopsis
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pilosula, Conioselinum univitatum, Atractylis ovata,
Glycyrrhiza glabra, Poria cocos, Angelica sinensis,
Cinnamomum loureirii, Astraglus hoantchy.
Say mat:




81. Yin Chiao Chieh Tu Pien
82. Peking Niu Huang Chieh Tu Pien
83. Superior Yin Chiao Sang Ju Wan
84. Ku Boon Pills
Ingredients
Yin cniao cnlen 'ru Flen:
Lonicera japonica, 'Forsythia suspensa, Arctium lappa,
Platycodon grandiflorum, Mentha arvensis, Glycine max,
Glycyrrhiza uralensis, Lophatherum gracile,
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Schizonepeta tenuifolia, Antelope, Paracetamolum,
Caffeinum. Chloroheniraminum.
Peking Niu Huang Chieh Tu Pien:
Calculus bovis, Rhizoma coptidis, Borneo camphor, Flos
Lonicerae, Herba Menthae, Radix scutellariae, Radix
Angelicae, Fructus gardeniae, Rhizoma Rhei, Rhizoma
ligustici.
Superior Yin Chiao Sang Ju Wan:
Honey-suckle, Flos Chrysanthemi, Wuzhigan, Geycyrrhiza
Uralensis Fisch, Sanyaku, Isatis Tinctorial,
Gangmeigen, Folium Mori, Farsythio.
Ku Boon Pills:
Panax ginseng, Herpestris monniera, Cuscuta chinensis,
Dioscorea batatas, Poria cocos, Cistance salsa,
Astraglus hoantchy, Rehmannia glutinosa, Lycium
chinense, Achyranthes bidentata, Cervus elaphus,
Paeonia albiflora, Cinnamomum loureirri, Citrus


























(e) Cantonese preserved food items
Chinese nameFood item
90. Salted fish Harm yu
Harm suen choi91. Cabbage fermented in brine
Harm dann92. Salted duck egg
Pay dann93. Fermented duck egg
(Thousand-year egg)
Yu to94. Fish sauce
95. Oyster sauce Ho yao
96. Moldy bean curd Fu yu
Kiu tau97. Pickled onion
Chi keun98. Pickled ginger
Mui choi99. Salted vegetables
100. Dried beef Au yuk gon
Chu yuk gon101. Dried pork
102. Dried lemon Ling mon gon
Kum quat103. Dried plum
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Rah mui104. Dried plum




A. EBV-EA induction by traditional Chinese medicine
(a) The results of EBV-EA inducing activity of single
Chinese medicinal herbs are summarized in Table 5.




















































































































































































































































































































































































































































































































































Control (n-butyrate alone) gave EBV-EA(%) 0.1 (0.02)
Among the 72 Chinese mecicinal herbs tested, only
Daphne genkwa showed a positive reaction. It had EBV-
EA inducing activity in the following concentrations:
1000 ug/ml, 100 ug/ml, 10 ug/ml, 1 ug/ml of ether
extract and 10 mg/ml, 5 mg/ml of water extract. Its
EBV inducing activity was comparable to those of the
strong inducers such as Croton oil, Euphorbia kansui
and Tung oil.
115
(b) EBV-EA inducing activity of Chinese tonic formulae
is shown in Table 6.
Table 6 EBV-EA inducing activity of tonic formulae
EBV-EAConcentrationTest substance
( % )(ug/ml)

































































Control (n-butyrate alone) gave EBV-EA(%) 0.1 (0.02)
(c) EBV-EA inducing activity of Chinese patent
medicines is shown in Table 7.
Table 7 EBV-EA inducing activity of patent medicines
EBV-EAConcentrationTest substance
( % )(ug/ml)







82. Peking Niu Huang Chieh Tu Pien






























Control (n-butyrate alone) gave EBV-EA(%) 0.1 (0.02)
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(d) EBV-EA inducing activity of the Chinese purgative
formulae tested is shown in Table 8.















































Control (n-butyrate alone) gave EBV-EA(%) 0.1 (0.02)
(e) Repeated exposure of Raji cells to Chinese
medicinal herbs
The 20 herbs selected in this study are listed in
the following:
3.Angelica pubescens, 5.Conioselinum univitatum,
121
11.Salvia miltiorrhiza, 12.Astraglus hoantchy,
17.Codonopsis pilosula, 20.Polygonatum officinale,
22.Rehmannia glutinosa, 23.Herpestris monniera,
25.Gastrodia elata, 27.Dendrobium moniliforme,
32.Stellera chamaejasme, 36.Polygonum multiflorum,
44.Dioscorea batatas, 45.Lycium chinense, 46.Eucommia
ulmoides, 49.Nelumbo nucifera, 55.Sparganium
stoloniferum, 63.Schizandra chinensis, 69.Cordyceps
sinensis, 70.Panax notoginseng
Small amount of samples were collected and assayed
for EBV-EA positive cells for every 48 hours in a
period of ten days. All samples of the 20 herbs
collected in this period showed less than 0.1% EA-
positive cells and considered as negative in the
reaction.
B. EBV-inducing activity of the Cantonese preserved
food items tested is shown in Table 9.
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C. Effect of sodium selenite on EBV-EA activation in
Raji cells
The cytotoxic effect of sodium selenite in the
range of 1 to 5 ug/ml is shown in Table 10 and the
growth curve of Raji cells in this range of
concentration of sodium selenite is shown in Fig. 6.
Table 10 Cytotoxic effect of selenite (1-5 ug/ml)
Percentage ofViabilityConcentration of










Fig.6. TOXIC EFFECT OF SODIUM SELENITE
(1-5ua/ml) ON RAJI CELLS













Concentration of sodium selenite (ug/ml)
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The effect of sodium selenite (1-5 ug/ml) on EBV
expression in Raji cells with varying concentrations of
Daphne genkwa is shown in Table 11-15 and Fig. 7
Table 11 Effect of sodium selenite (1-5 ug/ml) on EBV
expression
100 ug/m1 of Daphne genkwa
Percentage ofEBV-EAConcentration of









Table 12 Effect of sodium selenite (1-5 ug/ml) on EBV
expression.












Table 13 Effect of sodium selenite (1-5 ug/ml) on EBV
expression
60 ug/ml of Daphne genkwa
Percentage ofEBV-EAConcentration of









Table 14 Effect of sodium selenite (1-5 ug/ml) on EBV
expression
40 ug/ml of Daphne genkwa
Percentage ofEBV-EAConcentration of









Table 15 Effect of sodium selenite (1-5 ug/ml) on EBV
expression
20 ug/ml of Daphne genkwa.
Percentage ofEBV-EAConcentration of









Fig. 7 EFFECT OF SODIUM SELENITE














Concentration of sodium selenite (ug/ml)
30 ug/mI D. genkwa80 ug/ml D. genkwa100 ug/mi D. genkwa
20 ug/mI D. genkwa40 ug/mi D. genkwa
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The cytotoxic effect of sodium selenite in the
range of 0.25 to 1.25 ug/ml is shown in Table 16 and
the growth curve of Raji cells with these concentration
is shown in Fig. 8.
Table 16 Toxic effect of sodium selenite (0.25-1.25
ug/ml) on Raji cells
Percentage ofViabilityConcentration of









Fig. 8 TOXIC EFFECT OF SODIUM SELENITE
(O.25-1.25u/mI) ON RAJI CELLS













Concentration of sodium selenite (ug/ml)
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The effect of sodium selenite (0.25-1.25 ug/ml) on
EBV expression in Raji cells is with varying
concentrations of Daphne genkwa is shown in Table 17-21
and Fig. 9.
Table 17 Effect of sodium selenite (0.25-1.25 ug/ml)
on EBV expression
100 ug/ml of Daphne genkwa
Percentage ofEBV-EAConcentration of









Table 18 Effect of sodium selenite (0.25-1.25 ug/ml)
on EBV expression












Table 19 Effect of sodium selenite (0.25-1.25 ug/ml)
on EBV expression
60 ug/ml Daphne genkwa
Percentage ofEBV-EAConcentration of









Table 20 Effect of sodium selenite (0.25-1.25 ug/ml)
on EBV expression
40 ug/ml of Daphne genkwa
Percentage ofEBV-EAConcentration of









Table 21 Effect of sodium selenite (0.25-1.25 ug/ml)
on EBV expression
20 ug/ml of Daphne genkwa
Percentage ofConcentration of EBV-EA









Fig. 9 EFFECT OF SODIUM SELENITE
(0.25-1.25 ug/ml) ON EBV EXPRESSION













Concentration of sodium seienite (ug/ml)
60 ug/ml D. genkwa100 ug/ml D. genkwa 80 ug/ml D. genkwa
40 ug/m1 D. genkwal 20 ug/mI D. genkwa
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V DISCUSSION
A. EBV-EA inducing activity of Chinese medicinal herbs,
tonic formulae, patent medicines and purgative formulae
Both ether extract and water extract of the
Chinese medicinal. herbs and formulae were prepared for
the assay. Ether extract was made in order to obtain
the organic constituents of the herbs. As for water
extract, the purpose is to imitate the habit of Chinese
of taking the herbs in the form of soup or tonic after
boiling them with water.
It is noteworthy that the practice of Chinese
taking the herbs is in formulae, they seldom consume a
single herb alone. However, there are, thousands of
combinations of herbs in formulae, it is impractical to
test them. Therefore single herbs and some formulae
commonly consumed in Hong Kong were tested in this
study.
To date, several Chinese medicinal herbs from the
Euphorbiaceae and-'Thymelaeaceae families have been
reported to have strong EBV inducing activities [75,
76], such as Euphorbia kansui, Croton tiglium,
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Euphorbia lathyris, Euphorbia pekinensis, Daphne genkwa
and Aleurites fordii (tung oil tree).
As previously mentioned, tung oil tree are planted
along the main roads in Southern China and may
constitute an environment rich in EBV activating
substances from the plants. Nevertheless, there are
only a few tung oil trees in Hong Kong. Furthermore,
all the other five herbs are purgative drugs and they
are not commonly consumed in Hong Kong. Most of doctors
of traditional Chinese medicine will not normally
prescribe them unless they think it is absolutely
necessary because they are rather-toxic to the humans.
The possibility that the above EBV inducing
Chinese medicinal herbs are one of the etiological
factors for such a high incidence of NPC in Hong Kong
is very low.
4 of the 15 herbs reported to have EBV-EA inducing
activity in Raji cells by Zeng et al. [231] were
repeated in the present study. They are Daphne genkwa,
Stellera chamaejasme, Spaganium stoloniferum and
Angelica pubescens. Both the ether and water extracts
showed strong EBV inducing activity. The activity was
comparable to that of the control, Croton oil. For the
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other three herbs, the results were negative for both
extracts.
To account for the discrepancies of results in the
two studies, the major factor may be due to the fact
that Chinese medicinal herbs bearing the same name may
be of different origins, i.e. from different provinces,
or were collected during different seasons of the year.
Therefore the chemical contents may be different.
Recently, both the water and ether extract of
Daphne genkwa have been reported to have inducing
activity of EBV-EA in established nasopharyngeal hybrid
cells [232].
Several chemicals were identified from extract of
Daphne genkwa. They are genkwanin, hydroxygenkwanin,
apigenin, sitosterol, benzoic acid and irritant oils.
The indications of Daphne genkwa are excessive
sputum in the respiratory tract asthma with cough
edema lateral rib pain abdominal distention food•
poisoning splenomegaly in chronic malaria carbuncle.
Oral administration of a suitable quantity of
Daphne genkwa could induce an increase in the urinary
volume and excretion of sodium. Excessive oral dosage
would have a tendency to reduce urinary volume instead.
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Diuresis often caused diarrhea in rats and the
toxicity was even greater than those of Euphorbia
kansui and Euphorbia pekinensis. The safety margin was
narrow. Therefore it is not commonly prescribed by
doctors of traditional Chinese medicine in Hong Kong.
Besides Daphne genkwa, none of the 72 herbs tested
in the present study showed a positive reaction for
both extracts. The herbs selected are very commonly
consumed in Hong Kong.- Some of them such as Dioscorea
batatas, Lycium chinensis appear in most of the
formulae of tonic soup or tea. According to the
practice of Cantonese, these kinds of soup or tea are
made by boiling certain formulae of herbs with water
for several hours. They believe that taking these soup
frequently can give them energy and keep them healthy.
Herbs reported to give a positive reaction in the
synergistic assay method derived mostly from
Euphorbiaceae and Thymelaeaceae. In the present study,
three Chinese medicinal herbs from Thymelaeaceae were
tested. Only Daphne genkwa showed EBV inducing activity
while the other' two, Stellera chamaejasme and
Aquillaria agallocha gave negative results.
Two herbs, Caesalpinia sappan and Desmodium
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styracifolium from the family Leguminosae were found to
be positive in the study of Zeng et al. In the present
study, 4 herbs from the same family were tested. None
of them had EBV inducing activity.
Datura stramonium which belongs to Solanaceae was
found to have strong inducing activity in the study of
Zeng et al. Lycium chinensis of the same family was
found to be negative in the present study.
Furthermore, Angelica pubescens of Umbelliferae
was found to be weakly positive in Zeng's study. Five
herbs from the same family gave negative results in the
present study.
Some of the EBV inducers of herbs belong to the
same group of similar pharmacological action. The most
significant of them is purgative drugs. In the present
study, a herb with purgative action, Rheum officinale,
was tested. Furthermore, five formulae of purgative
action were tested.
Both extracts of Formula 85 showed strong EBV
inducing activity. It contained the strong EBV inducer
Euphorbia kansui. Similarly, both extracts of Formula
86 were strongly positive in the reaction. All the
three herbs in the formula were known to be EBV
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inducers.
As for Formulae 87, 88 and 89, both extracts gave
negative results. None of the herbs in the formulae had
been reported to have EBV inducing activity. Therefore
no new EBV inducer of purgative action were found.
Among the 72 herbs tested, 15 herbs are used by
doctors of trad.itional Chinese medicine to treat
cancers. They are 47.Lonicera japonica, 8.Prunella
vulgaris, 15.Euchresta japonica, 9.Scutellaria barbata,
57.Lithospermum erythrorhizon, 70.Panax notoginseng,
56.Pinella ternata, 61.Ficus carica, 21.Fritillaria
thumbergii, 51.Bombax malabaricum*, 37.Rheum officinale,
38.Ganoderma japonicum, 58.Oldenlandia diffusa,
69.Cordyceps sinensis, lO.Mesona chinensis.
These herbs are selected because if they have
anti-tumour property, they may be carcinogenic or toxic
to normal cells. They were tested for EBV inducing
activity to investigate the possibility of them to be
tumour promoters. it is noteworthy that two of these
herbs are used as tonic in general practice. They are
Cordyceps sinensis and Panax notoginseng.
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B. Repeated exposure of Raji cells to Chinese
medicinal herbs
Kinetic studies of EBV-EA induction in Raji cells
have been carried out in a number of EBV inducers:
saccharin, DDT, anthralin, iodoacetic acid [233] and n-
butyrate [71]. Optimal induction was obtained 2 days
after exposure for all of them. Longer exposure
resulted in a decrease of antigen-positive cells and in
cell death.
Therefore in experiments of screening EBV
inducers, the time of exposure of the lymphoblastoid
cells to test substances was fixed to be 48 hours
[231, 75, 76]. Since Chinese have the habit of taking
herbs as tonic frequently, the herbs may have
cumulative effect on the body. Thus' an experiment of
repeated exposure of Raji cells to Chinese medicinal
herbs was designed to investigate the cumulative'
effect.
20 herbs which were found to have no EBV inducing
activity after 2 days of exposure were selected to
perform this experiment. These 20 herbs include the 3
herbs which were reported to have EBV inducing activity
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in Zeng's study but gave negative results in the
present study and 17 herbs for tonic use.
After 10 days of repeated exposure of Raji cells
to the herbs, with small amount of samples assayed for
EBV-EA positive cells every 48 hours, all 20 herbs
still gave negative results.
C. EBV-EA inducing activity of Cantonese preserved food
items
Recently, case-control studies were carried out to
investigate the association of Cantonese food,
especially preserved ones, with NPC [149, 157].
Furthermore, an anthropological study conducted in
Southern China, Tunisia and Greenland suggested that
NPC could be associated with eating habits,
particularly consumption of preserved foods [234].
In the present study, 16 food items were tested
for EBV inducing activity. All of them are preserved
foods.
Yu et al. reported that chung choi was
significantly related to an increased risk of NPC
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[157]. Furthermore, samples of it (described by the
authors as radish roots and stem fermented in brine)
were found to contain nitrosamines in the study by
Poirier et al. [158]. However, chung choi showed no EBV
inducing activity in the present study.
Consumption of salted fish has been suggested as
an important risk factor for NPC [145, 146, 149].
Cantonese salted fish are prepared by salting fish in
brine and followed by 'drying in the sun. They may be
called tough or hard meat salted fish. Sometimes the
fish is allowed to soften by decomposition before
salting to prepare "soft meat" salted fish.
One sample of salted fish was tested for EBV
inducing activity and gave negative result. Zeng et al.
had also tested salted fish using the same method and
no EBV inducing activity was reported.
However, in a recent study by Shao et al. [235],
salted fish was tested for EBV-EA induction in Raji
cells. They reported that 3 out of 11 Cantonese salted
dried fish and shellfish samples of water extract were
found to contain substances that activate EBV. These
samples were one sample of Japanese mackerel and two
samples of squid. The activity found in these extracts
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of salted fish was comparable to those reported for
Chinese medicinal herbs [75, 76, 231].
Three extracts of each sample of salted fish were
prepared in Shao's study. They are aqueous, hexane and
ethyl acetate extracts. For all hexane and ethyl
acetate extracts of salted fish samples up to 62.5 mg
wet weight equivalent of food/ml medium, the results
were negative.
This is an important reason for the discrepancies
of results between the present study and Shao's study.
It is because in the present study, only ether extract
of each food sample was tested. No aqueous extract was
prepared. In Shao's study, EBV inducing activity was
only found in aqueous extracts of salted fish samples,
but not organic extracts.
Moreover, there are 'numerous species of Cantonese
salted fish, only one sample of a specie had been
tested. 8 out of 11 aqueous extracts of salted fish
showed negative reaction in Shao's study. To date, this
was the first demonstration of EBV inducing capacity
for Cantonese salted fish. Therefore only very small
fraction of salted fish was found to show positive
reaction in the synergistic assay method. Further
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samples of different varieties of salted fish should be
assayed.
On the other hand, Poirier et al. [158] reported
that 14 varieties of salted fish were found to contain
nitrosamines. The highest level of N-
nitrosodimethylamine (NDMA) was observed in high
salted, dried fil.let of garouper. However, the range of
NDMA levels in the 14 samples was wide (0-14 ug/ml)
with a mean of 3 ug/ml. Similar wide ranges of NDMA
levels in Chinese fish samples have been reported by
Fong and Chang [236], Huang et al. [237, 238, 239].
Such variations may reflect different modes of
preparation or even individual differences within a
given means of preparation.
Both samples of hard salted and soft salted
Japanese mackerel were found to contain 1.1 and 4.0
ug/mi of NDMA respectively. This finding together with
the demonstration of Cantonese salted fish contain,
substance(s) capable of strongly activating EBV
strengthen the proposal that salted fish is an
etiological factor for NPC.
Shao et al. [235] also reported negative reaction
for cabbage fermented in brine and it agreed with that
152
of the present study. However, in Poirier et al.'s
study, all three samples of cabbage fermented in brine
were found to contain nitrosamines with different
levels. One sample contained NDMA and N-
nitrosopyrrolidine (NPYR). The other two had N-
nitrosopiperidine (NPIP) in addition to NDMA and
(NPYR). The as.sociation of nitrosamine with EBV
inducing capacity in a substance needs further
investigation.
Since the synergistic assay method was derived
from the combined use of n-butyrate and TPA in the
expression of EBV antigen, it was not surprising that
active compounds structurally related to TPA can be
detected. Thus the TPA-related compounds, such as
phorbol 4-o-methyl-TPA, phorbol-12,13-didecanoate (PDD)
and, other phorbol diesters, which are potent tumour
promoters have been tested by this assay method and
yield definite positive results [75].
On the other hand, a compound phorbol which is
structurally related to TPA but lacking promoter
activity [240] is found to be negative in the reaction.
However, at this stage there is a question whether the
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assay can be useful in detecting tumour promoters other
than 'TPA' type.
Mezerine, a tumour promoting principle of Daphne
mezereum [241] has been proved to be an active EBV
inducer. It follows that many plants belong to
Thymelaeaceae containing active principles of daphnane
type diterpene esters are found to be positive in the
assay system.
Nevertheless, not every known tumour promoter
gives positive reaction in this system. Substances
which have been reported to be skin tumour promoters in
mouse experiments such as anthralin [242], phenol
[243], Tween 60 and 80 [244], gave negative results at
a maximum dose of 100 ug/mi. Moreover, some known
carcinogens (initiators), 3,4-benzpyrene,
aminoanthracene, nitroguanidine, nitroquinoline-N-oxide
and Butyl-hydrobutyl-nitrosamine showed no EBV inducing
activity at a dose of 50 ug/ml.
Therefore the- synergistic assay method have been
shown to miss a number of tumour promoters or
carcinogenic agents. It may be due to the fact that in
the process of ether extraction, substances like
retinoic acid having EBV inhibiting activity are
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simultaneously extracted together with the active
principles with EBV activating capacity giving false
negative results. This effect is much more significant
when testing a formula of Chinese medicinal herbs.
Since all the herbs of a formula are extracted all
together and therefore interaction between compounds in
the herbs may occur making the situation much more
complicated. The possibility of extracting EBV inducing
substances and EBV inhibiting substances simultaneously
are much greater. Therefore it is a major defect when
testing formulae of Chinese medicinal herbs. As
mentioned earlier, Cantonese seldom take single herb
alone, they consume them in formulae. It is possible
that the interactions between herbs in formula activate
EBV harboured in the body and contribute to the
causation of NPC. If this is the case, the synergistic
assay system may not be a suitable method to correlate
Cantonese habit of consuming medicinal herbs with the'
causation of NPC.
Furthermore, three classes of active agents have
been found to possess EBV inducing activity in this
system. They are the plant diterpene ester, microbial
indole alkaloids and factors in human physiological
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fluids. However, there may be promoters which contain
active agents other than the three groups and do react
with the system.
D. Effect of sodium selenite on EBV-EA activation
The synergistic assay method is not only used to
screen promoter substances, it can also be used to
screen agents with the capacity to inhibit EBV
activation and possibly to identify agents which may
have anti-promoter property.
In 1971, Shamberger first reported the
antipromoter activity of retinoic acid in mouse skin
carcinogenesis [245]. Later on, it was found that it
exerted inhibitory effect on EBV activation in vitro
[246, 247].
On the other hand, Ascorbic acid has long been
suggested to have suppression effect on neoplastic
growth [248]. By using the synergistic assay method,
Morigaki and Ito found that ascorbic acid inhibited the
induction of EBV-EA in Raji cells [74].
When a substance is tested for inhibitory effect
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on EBV activation in the synergistic assay method, it
is important to determine the toxicity of the substance
on the human lymphoblastoid cells. It can be done by
checking the viabilities of the cells when the
substance in varying concentrations are cultured with
the cells without any EBV inducing agent and compared
to that of the culture of cells alone. Information is
obtained on inhibitory, capacity as distinct from
cytotoxicity.
Several studies had been performed to investigate
the relationship between the essential element selenium
and cancer risk [226, 227, 228, 229]. All of these
investigations found that there is an inverse
relationship between selenium level and cancer risk.
In the present study, the inhibitory effect of
selenium (sodium selenite) on EBV activation in Raji
cells was investigated in the synergistic assay system.
The strong EBV inducer found in the present study,
Daphne genkwa, wag used.
From Fig. 6, it was observed that from 1 to 5
ug/ml of sodium selenite, the growth rate of Raji cells
dropped dramatically from 98.2% to 8.3%. It inferred
that sodium selenite was toxic to the lymphoblastoid
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cells within this range of concentration. From 0 to 1
ug/mi of selenite, the growth rate dropped very
slightly from 100% to 98.2%.
In Fig. 7, the percentage of EBV-EA positive cells
decreased as the concentration of sodium selenite
increased from 0 to 5 ug/ml. However, the inhibitory
effect of sodium selenite on EBV activation could not
be concluded because the toxicity of it (1-5 ug/ml) was
high. The inhibitory effect observed in this range of
concentration might be due to the toxicity of sodium
selenite. However, suppression of EBV-EA positive cells
was still observed in doses from 0 to 1 ug/ml of
selenite for varying concentrations of Daphne genkwa.
Therefore concentrations of sodium selenite were
confined to 0.25-1.25 ug/ml. In Fig. 8, it could be
seen that the cytotoxic effect of selenite was
remarkably low in this-range of. concentrations. At the
highest concentration of 1.25 ug/ml employed, the
growth curve of Raji cells showed a slight depression
of about 15%. Therefore it is the optimal range to
study the effect of selenite on EBV activation.
From Fig. 9, the suppressive effect of sodium
selenite with varying concentrations (0.25-1.25 ug/ml)
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on EBV-EA expression in Raji cells was obvious. The
percentage of EBV-EA producing cells as compared with
the untreated control cultures decreased as the
selenite concentration in the culture medium increased.
Inhibitory effect was observed for all 5
concentrations of- Daphne genkwa (20, 40, 60, 80, and
100 ug/ml) and the suppression curves showed a unique
pattern. The intervening effect of selenite was
approximately dose' dependent for all these
concentrations of Daphne genkwa.
At the higher doses of 1.00-1.25 ug/ml, the
percentage of suppression reached 80 to 90% for these
5 concentrations of Daphne genkwa. It was noteworthy
that at the lowest concentration employed, 20 ug/ml of
Daphne genkwa, complete inhibition was observed at such
doses (1.00-1.25 ug/ml) of selenite. Higher
concentration of Daphne genkwa could not yield complete
inhibition. The suppressive effect of selenite appeared
to be most significant at 20 ug/ml of Daphne genkwa and
this should be the optimal concentration used in this
study.
The present results agree with those of studies of
selenium level on carcinogenesis in animals [249, 250,
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251, 252, 253]. Almost all of these investigations have
found that high level of selenium treatments to cause
at least moderate (15 to 35%) reductions in tumour
incidence. The great majority of these studies using
animal tumour model systems have shown that high
selenium levels can inhibit or retard tumourigenesis.
The present finding shows inhibitory effect of selenite
on EBV-EA expression and thus may possess anti-promoter
property.
Furthermore, these results correspond with the
findings of Luo and Wu [254]. In their study of
cytotoxicity at 0.01-0.10 ug/ml of sodium selenite,
almost no effect on viability of Raji cells (85.69-
84.35%) was observed. When the concentration was 1.0
ug/ml, the viability was 77.44% and selenite was
mildly toxic to the cells. At a dose of 5 ug/ml- and
above, the toxicity of it was obvious. The viabilities'
of 'cells at 5 ug/ml and 10 ug/ml were only 24.82 and-
13.87% respectively.
In the study of intervening effect of sodium
selenite on EBV-EA expression in Raji cells, they used
three concentrations of selenite: 1, 5 and 10 ug/ml.
There is apparent decrease of EA positive cells in this
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range of concentrations. However, it might not due to
suppression by selenite because its toxicity was high
in these concentrations.
On the other hand, they used the B95-8 cell line
to investigate the effect of selenite on EBV-VCA
expression. The inhibitory effect was obvious at
varying concentrations of selenite (0.01-1.00 ug/ml)
and it followed a dose-dependent pattern.
The present results agree with those of Luo and
Wu. The viability of Raji cells in both studies begins
to drop significantly when the concentration of sodium
selenite is above 1 ug/ml. Furthermore, inhibition of
EBV activation is observed in both studies when
concentration of sodium selenite is below 1 ug/ml.
In conclusion, among the 72 single herbs tested
for EBV inducing activity in. the synergistic assay
method, only Daphne genkwa was found to be positive in
the reaction and had strong inducing activity. Further
studies should be carried out to investigate the. role
of it as tumour 'promoter. Animal studies can be
performed by feeding Daphne genkwa repeatedly to the
rats for a certain period of time with a carcinogen
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(initiator). Occurrence of tumour can then be tested.
Wikstroemia indica, a strong EBV inducer in the
synergistic assay system, has been found to promote
development of NPC in rats initiated by
dinitrosopiperazine [255].
Since only one sample of Cantonese salted fish was
tested in the present study, more samples and varieties
of it can be tested since-Shao et al. have reported the
first demonstration that Cantonese salted fish contain
substances capable of strongly activating EBV. Further
studies should be undertaken to isolate and identify
the active substance(s) in order to better understand
the role of salted fish in the etiology of NPC.
Results of case-control and animal studies support
that high selenium status can modify cancer risk.
Results of present study show that selenium has
inhibitory effect on EBV-EA expression in Raji cells
suggesting that it may have anti-promoter property.
Selenium intervention experiments should be designed to
further investigate whether improving selenium status
can decrease the risk of cancer in animals.
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APPENDIX
Name in ChineseTest substance
1. Siler divaricata 防 風
2. Angelica sinensis 當 歸
香 鐲 活3. Angelica pubescens
4. Heracleum lanatum 白 芷
川 芎
5. Conioselinum univitatum
6. Peucedanum decursivum 前 胡
7. Mentha arvensis 薄 荷 葉
8. Prunella vulgaris
夏 枯 草
9. Scutellaria barbata 半 枝 蓮
涼 粉 草10. Mesona chinensis
丹 參11. Salvia miltiorrhiza
黃 耆12. Astraglus hoantchy
13. Glycyrrhiza glabra 甘 草
赤 小 豆14. Phaseolus calcaratus
山 豆 根15. Euchresta japonica
桔 梗16. Platycodon grandiflorum
17. Codonopsis pilosula 當 參
沙 參18. Adenophora verticillata
土 茯 苓19. Smilax glabra






地 黃22. Rehmannia glutinosa
巴 戟23. Herpestris monniera
玄 參24. Scrophularia oldhami
天 麻
25. Gastrodia elata
白 芨26. Blettia striata
石 斛27. Dendrobium moniliforme
大 小 蓟
28. Cirsium japonicum.
白 朮29. Atractylis ovata
木 香30. Saussurea lappa
芜 花31. Daphne genkwa
瑞 香 狼 毒32. Stellera chamaejasme
沉 香33. Aquillaria agallocha
枇 杷 葉34. Eriobotrya japonica
山 楂
35. Crategus pinnatifida
何 首 烏36. Polygonum multiflorum
大 黃37.Rheum officinale
木 靈 芝38. Ganoderma japonicum
茯 神39. Poria cocos
白 頭 翁40. Pulsatilla chinensis
41. Paeonia albiflora 白 芍
42. Citrus aurantium 陳 皮
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Name in ChineseTest substance
枳 實
43. Poncirus trifoliata
淮 山44. Dioscorea batatas
杞 子45. Lycium chinense
杜 仲46. Eucommia ulmoides
金 銀 花47. Lonicera japonica
茅 根
48. Imperata arundinacea
49. Nelumbo nucifera 蓮 子
百 部
50. Stemona japonica
木 棉 花51. Bombax malabaricum
52. Ephedra sinica 麻 黃
53. Plantago asiatica 車 前 子
防 已54. Cocculus trilobus
荊 三 稜55. Sparganium Stoloniferum
56. Pinellia ternata 半 夏
57. Lithospermum erythrorhizon 紫 草
58. Oldenlandia diffusa





木 通62. Akebia quinata
五 味 子63. Schizandra chinensis
竹 茹64. Phyllostachys nigra











73. Ching po leung
74. Ya say mei
75. Ng fa char





81. Yin Chiao Chieh Tu Pien
82. Peking N.iu Huang Chieh Tu Pien
83. Superior Yin Chiao Sang Ju Wan
84. Ku Boon Pills
90. Salted fish




銀 杏 （ 白 果 ）
牛 膝












銀 翘 解 毒 片
北 京 牛 黃 解 毒 片





Name in ChineseTest substance
92. Salted duck egg 咸 蛋
93. Fermented duck egg 皮 蛋
94. Fish sauce
魚 露
95. Oyster sauce 蠔 油
96. Moldy bean curd 腐 乳
97. Pickled onion
蕎 頭
子 恙98. Pickled ginger
99. Salted vegetables 霉 菜
牛 肉 乾
100. Dried beef
豬 肉 乾101. Dried pork
檸 檬 乾102. Dried lemon
甘 橘
103. Dried plum
104. Dried plum 話 梅




Raji cells in RPMI 1640 medium
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